Brightpath Neuro Assessment is a private mental health service specializing in comprehensive assessments and tailored treatment plans for neurodevelopmental and mental health conditions. We provide expert support for: Autism (ASC) ADHD Dyslexia Common mental health disorders, including anxiety, depression, and sleep issues Our experienced team of professionals is committed to helping individuals understand their challenges and develop effective strategies to improve their well-being.

Flexible Payment Options Pay Later Option: If you prefer to spread the cost or need additional flexibility, we offer a secure "Pay Later" option through PayPal. This allows you to book your appointment immediately without the need to pay upfront. You can complete your payment later at a time that suits you, helping to reduce any financial strain. This option is particularly helpful for those managing a budget or needing to coordinate payments with other financial commitments.

👉 Pay with PayPal   You can also scan the QR code below to complete your payment quickly and securely through PayPal. This gives you the freedom to manage your booking and payment from your mobile device, making it even more convenient.  

👉 PayPal "Buy Now, Pay Later   If you use this code,

please: Email: Send us an email at:

👉 [email protected] with your request, and a member of our team will get back to you promptly.

Phone: Call us directly at:

👉 +442038568602 to discuss your needs and schedule an appointment. Our team will confirm your booking and provide any additional information or preparation details needed before your assessment or consultation.

Please note that the PayPal "Buy Now, Pay Later" option is a service offered directly by PayPal. Brightpath Neuro has no control over PayPal’s terms or outcomes related to this service. Any issues or disputes regarding PayPal payments should be directed to PayPal's customer support for resolution.

Terms and Conditions

1. Introduction Welcome to Brightpath Neuro. These Terms and Conditions ("Terms") govern your use of our services, website, and products. By accessing or using our services, you agree to be bound by these Terms. If you do not agree to these Terms, please do not use our services.

2. Definitions "We", "Us", "Our" – Refers to Brightpath Neuro. "You", "Your" – Refers to the customer, client, or user of our services. "Services" – Refers to all assessments, consultations, and support services provided by Brightpath Neuro.

3. Services We provide professional neurodiversity and mental health assessments and support, including but not limited to: ADHD, Autism (ASC), and Dyslexia Assessments Sleep Assessments Weight Management Services Mood and Mental Health Support All services are provided by qualified professionals and are tailored to individual needs. We reserve the right to modify or withdraw any of our services without prior notice.

4. Payment Terms Full payment is required at the time of booking unless otherwise agreed. Payments are processed securely via our online payment system. Failure to make payment may result in the cancellation of your booking. Refunds are available only under specific circumstances (see Section 6).

5. Cancellations and Rescheduling Cancellations made more than 48 hours before an appointment are eligible for rescheduling or a full refund. Cancellations made within 48 hours of an appointment may be subject to a cancellation fee of up to 50% of the service fee. Failure to attend an appointment without prior notice will result in a full charge for the service.

6. Refund Policy Refunds are only offered if: The service is cancelled by Brightpath Neuro. The service is not delivered as described due to an error on our part. A medical or personal emergency prevents you from attending, and evidence is provided.

7. User Obligations By using our services, you agree to: Provide accurate and complete information when booking and during assessments. Follow professional advice and recommendations to the best of your ability. Treat our staff with respect and professionalism.

8. Data Protection and Privacy Your personal information is processed according to our Privacy Policy. We are committed to protecting your personal data and only use it for the purpose of providing and improving our services.

9. Limitation of Liability Brightpath Neuro is not liable for any indirect or consequential loss resulting from the use of our services. Our total liability for any claim arising out of these Terms is limited to the amount paid for the service.

10. Governing Law These Terms are governed by and interpreted in accordance with the laws of England and Wales. Any disputes will be subject to the exclusive jurisdiction of the courts of England and Wales.

11. Changes to Terms We may update these Terms at any time. Any changes will be communicated via our website. Your continued use of our services constitutes acceptance of the updated Terms.

Privacy Policy

1. Introduction At Brightpath Neuro, we value your privacy and are committed to protecting your personal information. This Privacy Policy outlines how we collect, use, store, and protect your data in compliance with the UK General Data Protection Regulation (UK GDPR) and the Data Protection Act 2018.

2. Data We Collect We collect the following types of personal data: Personal Information – Name, date of birth, contact details (email, phone, address). Health Information – Medical history, diagnostic information, and assessment data (only where necessary). Payment Information – Payment details processed securely through third-party providers. Usage Data – Information about how you use our website and services.

3. How We Collect Data We collect your data through: Direct interactions (e.g., booking forms, consultations). Automated technologies (e.g., cookies and website analytics). Third parties (e.g., referral agencies or medical professionals).

4. How We Use Your Data We use your personal data to: Provide and manage our services. Process payments and manage bookings. Communicate with you regarding your care and appointments. Improve our services and customer experience. Comply with legal and regulatory obligations.

5. Data Sharing We may share your data with: Medical professionals involved in your care (with your consent). Third-party payment processors (to process payments securely). Legal or regulatory bodies if required by law. We do not sell your data to third parties.

6. Data Retention We retain your data only for as long as necessary to fulfill the purposes outlined in this policy. Health records are retained in accordance with NHS guidelines and legal requirements.

7. Your Rights You have the right to: Access your data and request a copy of the information we hold. Request corrections to inaccurate or incomplete data. Request deletion of your data (where legally permitted). Object to the processing of your data for specific purposes. Withdraw consent for data processing at any time.

8. Data Security We implement appropriate security measures to protect your data, including encryption, secure servers, and restricted access.

9. Cookies Our website uses cookies to improve functionality and user experience. By continuing to use our site, you consent to the use of cookies as described in our Cookie Policy.

10. Complaints and Contact If you have any concerns about how we handle your data, you can contact us at: Email: [email protected] Phone: +44 20 3856 8602 You also have the right to lodge a complaint with the Information Commissioner's Office (ICO) if you believe your data rights have been violated.

11. Changes to This Policy We may update this Privacy Policy from time to time. Any changes will be posted on our website, and continued use of our services will constitute acceptance of the revised terms.

1. Introduction   BrightPath Neuro is committed to providing high-quality, person-centred care in compliance with relevant legislation, professional standards, and best practice guidelines. Consent is a fundamental component of providing care and treatment, ensuring that individuals retain control over their healthcare decisions and are treated with dignity and respect.   This policy sets out the process by which BrightPath Neuro will seek, obtain, and record consent for the provision of care and treatment. It ensures that individuals are fully informed of their options, understand the nature and purpose of the proposed care or treatment, and are able to give consent freely and voluntarily.   This policy applies to all staff and practitioners at BrightPath Neuro involved in providing care and treatment and must be followed consistently. The policy reflects our commitment to ensuring that consent is obtained in a lawful and ethical manner, respecting the autonomy and preferences of each individual.  

👉 Click here to sign our consent to Treatment and Sharing of information  

2. Purpose   The purpose of this policy is to:   Ensure that all care and treatment provided by BrightPath Neuro is carried out with the informed consent of the individual. Ensure that the process for obtaining consent complies with relevant legislation, including the Mental Capacity Act 2005 (MCA) and the Deprivation of Liberty Safeguards (DoLS). Protect the rights and interests of individuals who lack the capacity to give consent. Provide clear guidance to staff on how to seek and record consent appropriately. Ensure that the process for seeking consent is transparent, consistent, and documented accurately. Ensure compliance with the standards required under ISO 9001 certification, which reflects BrightPath Neuro’s commitment to quality and continuous improvement in the delivery of care and treatment.  

3. Scope   This policy applies to:   All staff employed or contracted by BrightPath Neuro, including temporary and agency staff. All individuals receiving care, diagnosis, or treatment from BrightPath Neuro. All consent obtained prior to the commencement of an assessment, diagnosis, or treatment. All individuals over the age of 16, unless the individual is deemed to lack capacity under the Mental Capacity Act 2005. The following specific types of assessment and treatment provided at BrightPath Neuro: ADHD (attention deficit hyperactivity disorder) ASC (Autism Spectrum Condition) Dyslexia Common Mood disorders (e.g., depression and anxiety) Common Sleep disorders Weight Management (including dietary assessment, medication, exercise programmes, and treatment plans)   Consent must be obtained before any assessment, diagnosis, or treatment is conducted. This includes, but is not limited to, the completion of initial assessment forms, diagnostic interviews, psychological testing, and pharmacological interventions.  

4. Legislative and Regulatory Framework   This policy is written in accordance with the following legislation, guidance, and professional standards:   The Mental Capacity Act 2005 The Mental Health Act 1983 (as amended 2007) The Care Act 2014 The Human Rights Act 1998 The Deprivation of Liberty Safeguards (DoLS) General Data Protection Regulation (GDPR) (2018) The Equality Act 2010 National Institute for Health and Care Excellence (NICE) guidelines ISO 9001 Certification Standards   BrightPath Neuro holds ISO 9001 certification, demonstrating our commitment to quality management and continuous improvement in all aspects of our service. This certification reflects that our consent process meets the highest standards of care and governance.  

5. The Mental Capacity Act (MCA) 2005 – Five Key Principles   All staff at BrightPath Neuro must work in accordance with the five key principles of the Mental Capacity Act 2005 when seeking consent or making decisions on behalf of an individual:   Presumption of capacity – Every adult has the right to make their own decisions unless proven otherwise. Right to make unwise decisions – Individuals have the right to make decisions that may appear unwise to others, provided they have capacity. Support to make decisions – Individuals must be given all practicable support to make their own decisions, including the use of communication aids if required. Best interests – If an individual lacks capacity, any decision made on their behalf must be in their best interests. Least restrictive option – Any action taken on behalf of someone without capacity must be the least restrictive of their rights and freedoms.    

6. Informed Consent   Consent must be:   Voluntary – Given freely without coercion, undue influence, or pressure. Informed – The individual must receive clear and accurate information about the nature and purpose of the care or treatment, including the risks, benefits, and alternatives. Capacitated – The individual must have the mental capacity to give consent.   To ensure that consent is informed, the following information must be provided:   The nature and purpose of the proposed treatment or care. Any potential risks, side effects, or complications. Any alternative options available, including the option to decline treatment. The right to withdraw consent at any time without consequence.      

7. Seeking Consent   Consent must be sought before any care or treatment is provided.   All individuals receiving care or treatment from BrightPath Neuro are required to complete a Consent Form before any assessment, diagnosis, or treatment is conducted. This form can be accessed through the BrightPath Neuro website or directly from staff.   Consent is required before any of the following assessments or treatments are initiated:   ADHD assessments (including diagnostic interviews, psychometric testing, and medication reviews) ASC assessments (including observation, structured interviews, and ADOS assessments) Dyslexia assessments (including cognitive and educational testing) Mood disorder assessments (including structured diagnostic interviews and psychometric testing) Sleep disorder assessments (including sleep studies and cognitive-behavioural interventions) Weight Management assessments (including dietary assessment, exercise planning, medication, and treatment plans)   Staff must ensure that:   Consent is obtained before any assessment, diagnosis, or treatment begins. The individual understands the information provided and can ask questions. The individual has sufficient time to consider their decision. Consent is documented clearly and accurately in the individual’s care record.  

8. Capacity and Best Interests   If an individual lacks the capacity to give consent, the following steps must be taken:   A formal capacity assessment must be completed by a qualified practitioner. If the individual is deemed to lack capacity, a decision must be made in their best interests. The individual’s family, carers, and advocates must be involved in the decision-making process, where appropriate. The least restrictive option must be used to meet the individual’s needs. Decisions made on behalf of the individual must be documented in full.  

9. Accessibility of this Policy   This policy is available to all individuals receiving care from BrightPath Neuro. If required, the policy can be provided in an Easy Read format or in alternative formats (e.g., large print, audio) to meet the communication needs of the individual. Individuals or their representatives may request an accessible version by contacting BrightPath Neuro’s administrative team.   BrightPath Neuro’s staff are trained to provide support and guidance in understanding the contents of this policy and the process for giving consent.  

10. Advocacy and Support   BrightPath Neuro will provide support to individuals who require additional help to understand and make decisions about their care. Where appropriate, BrightPath Neuro will:   Arrange for an Independent Mental Capacity Advocate (IMCA). Work with family members and carers to ensure the individual’s best interests are represented. Encourage individuals to involve their own advocates or legal representatives.  

11. Documentation and Record-Keeping   All consent must be recorded clearly in the individual’s care record, including:   The date and time consent were obtained. The nature of the proposed care or treatment. The information provided to the individual. The individual's decision (consent or refusal). Any questions raised and the responses provided.  

12. Monitoring and Review   This policy will be reviewed annually to ensure it reflects current legislation, guidelines, and best practice.   BrightPath Neuro’s Safeguarding Policy meets all CQC KLOE requirements and reflects national best practices and legal standards. The structured governance, monitoring, and improvement framework ensures that safeguarding is consistently effective and person-centred.   1. Safe (S) The policy meets the requirements for ensuring that service users are protected from harm, abuse, and neglect: S1 – How do systems, processes, and practices keep people safe and safeguarded from abuse? The policy outlines a clear framework for identifying, reporting, and managing safeguarding concerns. It establishes safeguarding procedures, including staff responsibilities and escalation protocols. Staff are trained to recognise signs of abuse and respond appropriately. Incident reporting and investigation processes are clearly defined. S2 – How are risks to people assessed, and how are they monitored and managed so they are supported to stay safe? The policy includes structured risk assessment processes to identify safeguarding risks. Protective measures, including care plans and psychological support, are implemented to reduce identified risks. Environmental adjustments are made to minimise safeguarding risks. Action plans are created to manage and mitigate risks following safeguarding incidents. S3 – How does the service ensure the proper and safe use of medicines? While not directly related to safeguarding, medication safety and management are handled through separate governance policies in alignment with safeguarding responsibilities (e.g., preventing misuse or coercion). S4 – How does the provider ensure the premises and equipment are safe and that people are protected from avoidable harm? The safeguarding policy includes procedures for protecting service users from environmental hazards and institutional abuse. S5 – What is the track record on safety? The policy outlines auditing and incident review procedures to ensure continuous improvement in safeguarding measures. Regular analysis of safeguarding data is conducted to identify trends and address gaps.  

2. Effective (E) The policy meets the requirements for ensuring that safeguarding measures are effective and evidence-based: E1 – Are people’s needs and choices assessed, and is care, treatment, and support delivered in line with current legislation, standards, and evidence-based guidance? The policy aligns with the Care Act 2014, Children Act 1989 and 2004, NICE guidelines, and the Safeguarding Vulnerable Groups Act 2006. Safeguarding practices are based on evidence-based guidance and best practices from NHS and NICE. Service users are involved in decisions about their care and safeguarding plans. E2 – How does the service ensure that staff have the skills, knowledge, and experience to deliver effective care, support, and treatment? Safeguarding training is mandatory for all staff during induction and annually thereafter. Scenario-based learning and competency assessments ensure staff readiness to manage safeguarding issues. Staff competence is monitored and reviewed annually. E3 – How are staff, teams, and services working together to deliver effective care and support? The policy outlines multi-agency collaboration with local authority safeguarding teams, social services, and healthcare providers. Joint investigations and information sharing protocols are established to manage safeguarding cases effectively. E4 – How are people supported to live healthier lives and access care, support, and treatment? The safeguarding policy supports service users’ autonomy and involvement in decision-making. Advocacy services are available to support vulnerable service users in understanding their safeguarding rights. E5 – How are people’s outcomes improved and sustainability of care ensured? Action plans from safeguarding incidents are reviewed to prevent recurrence and improve care outcomes. Service improvements are based on audit findings and safeguarding trends.  

3. Caring (C) The policy meets the requirements for providing safeguarding measures that are person-centred and compassionate: C1 – How does the service ensure that people are treated with kindness, respect, and compassion, and that they are given emotional support when needed? Staff are trained to respond to safeguarding disclosures with sensitivity and compassion. Service users are supported emotionally throughout the safeguarding process. Psychological support is available for individuals affected by safeguarding concerns. C2 – How does the service support people to express their views and be actively involved in making decisions about their care and treatment as far as possible? The safeguarding policy supports informed consent and empowers service users to make decisions about safeguarding actions. Service users are provided with advocacy support where required. C3 – How is people’s privacy and dignity respected? The safeguarding policy outlines strict confidentiality protocols for safeguarding reports and investigations. Personal data is handled securely in line with GDPR requirements. Staff are trained to handle sensitive information respectfully and professionally.  

4. Responsive (R) The policy meets the requirements for ensuring that safeguarding processes are responsive and individualised: R1 – How do people receive personalised care that is responsive to their needs? Safeguarding responses are tailored to individual needs, risk levels, and personal circumstances. Personalised safeguarding plans are developed in consultation with the service user and relevant agencies. R2 – How does the service listen to and respond to complaints and concerns? Service users and staff can raise safeguarding concerns through an online system or direct reporting. All safeguarding concerns are investigated and resolved promptly. R3 – How are people’s concerns and complaints listened and responded to, and used to improve the quality of care? Findings from safeguarding investigations are used to adjust care plans and improve safeguarding protocols. Learning from safeguarding incidents is shared with staff through feedback and training updates.  

5. Well-Led (W) The policy meets the requirements for ensuring that safeguarding governance and leadership are strong and effective: W1 – Is there a clear vision and credible strategy to deliver high-quality care and support? The safeguarding policy defines clear roles, responsibilities, and escalation pathways. The Safeguarding Lead (Steven Davis) is accountable for ensuring compliance with safeguarding standards. W2 – Is there a clear governance framework that ensures quality, performance, and risk are managed effectively? The policy outlines an ISO 9001-aligned governance framework for safeguarding. Safeguarding performance data is reviewed regularly at governance meetings. W3 – Are the leaders aware of the risks and challenges, and are they acting to address them? Regular audits, incident reviews, and safeguarding reports are used to identify trends and emerging risks. Corrective actions are implemented to address safeguarding gaps. W4 – How does the service continuously learn, improve, and innovate? Findings from audits and safeguarding reviews are incorporated into training and policy updates. Action plans from safeguarding incidents are reviewed and adjusted based on outcomes. W5 – How does the service work in partnership with other agencies? The policy establishes clear collaboration with local authorities, social services, healthcare providers, and law enforcement. Multi-agency meetings are held to review complex safeguarding cases and ensure coordinated responses.   Summary of CQC KLOE Compliance KLOE Level of Compliance Comments Safe (S) Fully compliant Strong safeguarding framework and incident reporting processes in place. Effective (E) Fully compliant Aligned with NICE and NHS guidelines, strong staff training. Caring (C) Fully compliant Emphasis on service user involvement and emotional support. Responsive (R) Fully compliant Clear escalation pathways and personalised safeguarding plans. Well-Led (W) Fully compliant Strong leadership and governance structure.

Conclusion BrightPath Neuro’s Safeguarding Policy meets all CQC KLOE requirements and reflects national best practices and legal standards. The structured governance, monitoring, and improvement framework ensures that safeguarding is consistently effective and person-centred.  

Policy Lead: Paul Davis, Director of Operations Consent Practitioner: Melanie Kennett, Registered Mental Health Nurse (RMN)  Date Created: 21 March 2025 Next Review Date: 21 March 2026

1. Introduction   BrightPath Neuro is committed to creating and maintaining an inclusive environment that promotes equality, celebrates diversity, and upholds the principles of fairness and respect for all individuals. This policy ensures that all service users, staff, volunteers, and stakeholders are treated equitably, regardless of their background or characteristics.   Equality, diversity, and inclusion are embedded into every aspect of our service delivery, from assessments and therapeutic interventions to organisational practices and staff recruitment. By fostering a culture of acceptance and understanding, BrightPath Neuro enables individuals to thrive, feel valued, and be supported in achieving their full potential.   This policy reflects BrightPath Neuro’s dedication to meeting its legal and ethical obligations under the Equality Act 2010 and the Human Rights Act 1998. We are also committed to meeting the Accessible Information Standard to ensure that everyone, including individuals with disabilities, can access and use our services on an equal basis.  

2. Purpose   The purpose of this policy is to:   Ensure that all individuals, regardless of their characteristics, are treated with dignity, respect, and fairness. Embed equality, diversity, and inclusion into our organisational practices, policies, and service delivery. Identify and eliminate discriminatory practices, behaviours, or barriers within the organisation. Promote a culture where diversity is celebrated, and all individuals feel a sense of belonging. Ensure compliance with the Accessible Information Standard and uphold the rights of all individuals under the Equality Act 2010 and the Human Rights Act 1998.   By adhering to this policy, BrightPath Neuro meets its ethical and legal obligations to protect individuals from discrimination and create an equitable environment for all.  

3. Scope   This policy applies to:   All employees, contractors, volunteers, service users, and external partners of BrightPath Neuro. All aspects of BrightPath Neuro’s service delivery, including: Clinical assessments and interventions Staff recruitment, training, and development External partnerships and collaborations Digital and online services Telephone-based services All environments where BrightPath Neuro operates, including clinical settings, virtual platforms, and external events.   Every individual associated with BrightPath Neuro is responsible for upholding the principles of equality, diversity, and inclusion in their interactions and practices.  

4. Legislative Framework   BrightPath Neuro’s Equality, Diversity, and Inclusion Policy is underpinned by the following legislation:   The Equality Act 2010   Protects individuals from discrimination based on protected characteristics, including:   Age Disability Gender reassignment Marriage and civil partnership Pregnancy and maternity Race Religion or belief Sex Sexual orientation   Defines direct and indirect discrimination, harassment, and victimisation as unlawful practices.   The Human Rights Act 1998   Safeguards fundamental rights, including the right to: Freedom from discrimination Respect for private and family life Freedom of thought, conscience, and religion   The Employment Rights Act 1996   Protects employees from unfair treatment, dismissal, or discrimination in the workplace.   The Public Sector Equality Duty (Equality Act 2010)   Requires public bodies and associated organisations to: Eliminate discrimination Advance equality of opportunity Foster good relations between people from different backgrounds    

5. Definitions of Equality, Diversity, and Inclusion   Equality   Ensuring that everyone has access to the same opportunities and is treated fairly, irrespective of their background or characteristics. Equality does not mean treating everyone the same but recognising and accommodating differences to achieve fairness.   Diversity Recognising, valuing, and respecting the differences between individuals, including their backgrounds, experiences, and perspectives. Diversity encompasses both visible and invisible characteristics, such as ethnicity, gender, age, disability, sexual orientation, and more. Inclusion   Creating an environment where everyone feels welcomed, valued, and supported to participate fully and contribute meaningfully. Inclusion ensures that individuals are not excluded due to barriers, biases, or prejudices.  

6. Principles of Equality, Diversity, and Inclusion   BrightPath Neuro is guided by the following principles:   Respect and Dignity: All individuals are treated with respect and dignity, regardless of their characteristics or circumstances. Fairness and Opportunity: Barriers to participation and advancement are identified and removed, ensuring equal opportunities for all. Valuing Diversity: Diversity is celebrated as a strength that enriches our organisation and enhances our service delivery. Zero Tolerance for Discrimination: Discrimination, harassment, and victimisation are not tolerated and will be addressed promptly and effectively. Accountability: All staff and stakeholders are responsible for upholding the principles of equality, diversity, and inclusion in their roles.  

7. Responsibilities   All staff, volunteers, and stakeholders of BrightPath Neuro share responsibility for promoting equality, diversity, and inclusion. This includes:   Recognising and Addressing Bias: Identifying and challenging unconscious biases that may influence behaviour or decision-making. Creating an Inclusive Environment: Ensuring that workspaces and practices are accessible, welcoming, and inclusive for all individuals. Reporting Discrimination: Raising concerns about discriminatory practices or behaviours promptly. Adhering to Policies: Complying with BrightPath Neuro’s Equality, Diversity, and Inclusion Policy and associated procedures.   Equality, Diversity, and Human Rights Lead: Tianny Brown oversees the implementation of this policy, ensuring compliance and providing guidance on best practices.  

8. Meeting the Accessible Information Standard   BrightPath Neuro is committed to meeting the requirements of the Accessible Information Standard by: Providing information in accessible formats (e.g., large print, audio, easy read). Making reasonable adjustments to enable individuals with disabilities to access and use our services on an equal basis. Ensuring that online platforms and telephone services are easy to use and accessible. Recording individuals' communication needs and preferences in their records. Sharing relevant information with other providers or services (with consent) to ensure that communication needs are consistently met.  

9. Reporting Equality, Diversity, and Inclusion Concerns   BrightPath Neuro is committed to addressing any concerns or incidents relating to equality, diversity, and inclusion promptly and effectively.   Steps to Report a Concern:   Identify the Concern: Observe and document the incident or practice that breaches the principles of equality, diversity, or inclusion. Immediate Action: If urgent, raise the concern with a supervisor or the Equality, Diversity, and Inclusion Lead.

Report the Concern: Visit www.brightpathneuro.co.uk to access the online reporting form. Provide detailed information about the concern, including any actions already taken. Internal Review: The Equality, Diversity, and Inclusion Lead will review the report and take appropriate action, which may include mediation, disciplinary action, or referral to external bodies.  

All reports are treated confidentially and in compliance with data protection regulations.  

10.  👉 Submit a Complaint or Scan for Complaint form:      

11. Promoting Diversity, Inclusion, and Supporting Underrepresented Groups At BrightPath Neuro, we are committed to fostering an inclusive environment that recognizes and values diversity across all areas of our service provision. We actively promote the inclusion and equitable treatment of minority ethnic groups, LGBTQ+ individuals, and other underrepresented communities to ensure they have equal access to high-quality mental health and neurodivergent care. Our approach includes targeted outreach, culturally sensitive care, and ongoing advocacy to remove barriers and improve outcomes for these communities.  

11.1 Collaboration with Policymakers and Community Engagement BrightPath Neuro is actively collaborating with a Member of Parliament (MP) in London to raise awareness and address the mental health and neurodivergent needs of minority ethnic and underrepresented communities. This collaboration focuses on: Increasing public and political awareness of mental health and neurodivergent issues within diverse communities. Developing policies and strategies that reflect the specific challenges faced by minority groups. Ensuring that funding and resource allocation within mental health services meet the needs of these communities. Through these partnerships, BrightPath Neuro aims to influence national and local policy to reduce health inequalities and improve access to appropriate care.  

11.2 LGBTQ+ Support and Inclusive Practice BrightPath Neuro has established a dedicated LGBTQ+ support group to provide a safe and supportive environment for neurodivergent individuals within the LGBTQ+ community. The group is facilitated by experienced mental health practitioners trained in LGBTQ+ issues. Sessions are designed to explore the intersection between neurodiversity, mental health, and LGBTQ+ identity, providing tailored emotional and practical support. Our services are fully inclusive of gender identity and sexual orientation, ensuring that all individuals feel respected and understood. Gender-neutral language and pronouns are used across all client communications and records. Staff receive ongoing training on LGBTQ+ awareness and sensitivity to improve clinical practice.  

11.3 Culturally Sensitive Care and Minority Ethnic Inclusion BrightPath Neuro recognizes the importance of providing culturally competent care that reflects the backgrounds and experiences of our clients. All staff receive training on cultural competence and anti-discriminatory practice to ensure they understand the impact of culture, religion, and ethnicity on mental health and neurodivergence. Assessment tools and treatment plans are adapted to reflect cultural differences and reduce diagnostic bias. Information about our services is available in multiple languages and formats to increase accessibility. Community outreach programs have been established to improve engagement with minority ethnic communities, including: Partnering with local faith and community leaders to build trust and increase service awareness. Providing workshops and psychoeducation sessions within culturally relevant settings. Actively recruiting staff from diverse backgrounds to reflect the communities we serve.  

11.4 Addressing Health Inequalities and Barriers to Access BrightPath Neuro is committed to identifying and addressing barriers that prevent minority and underrepresented groups from accessing care. We have identified key challenges, including: Language barriers. Fear of discrimination or stigma. Lack of culturally appropriate services. Mistrust in healthcare providers. To address these barriers, BrightPath Neuro has implemented the following measures: Flexible appointment options, including evenings and weekends. Offering interpreters and translated materials for non-English speakers. Providing culturally adapted psychoeducation and support groups. Developing a feedback system to capture the views of minority and underrepresented groups and make necessary service adjustments.  

11.5 Data Monitoring and Continuous Improvement We systematically collect and monitor demographic data to assess how well our services are meeting the needs of diverse communities. This data is used to identify disparities in access, treatment, and outcomes for minority and underrepresented groups. Annual service reviews are conducted to evaluate the effectiveness of our inclusion strategies. Findings are used to inform service improvements and ensure equity in service delivery. All incidents of discrimination, bias, or inequity are investigated under BrightPath Neuro’s complaints and safeguarding procedures, with clear action plans developed to prevent recurrence.  

11.6 Advocacy and Influence on National Policy BrightPath Neuro engages in national advocacy to ensure that mental health and neurodivergent services reflect the diverse needs of the population. We actively participate in consultations and advisory groups to influence national health policies. We work closely with local authorities, NHS Trusts, and third-sector organizations to promote greater funding and resource allocation for underrepresented groups. Through our partnerships with policymakers, advocacy groups, and professional bodies, we are working to create systemic change that reduces health disparities and promotes equitable access to care for all.  

12. Reasonable Adjustments and Accessibility BrightPath Neuro is committed to ensuring that all individuals, including those with disabilities, communication difficulties, and neurodivergent needs, can access and benefit from our services. We recognize that providing reasonable adjustments is essential to creating an inclusive and accessible environment. Our approach includes adapting communication methods, simplifying access to information, and offering tailored support to meet individual needs.  

12.1 Accessible Information and Communication To improve accessibility, BrightPath Neuro has enhanced its website and service materials to meet the needs of individuals with diverse communication styles and cognitive abilities. We have introduced: Easy Read Materials – All key information, including details about each pathway, is available in an Easy Read format. This includes simplified language, clear structure, and visual aids to improve understanding. Video Guides – Each assessment pathway is explained through short, accessible videos featuring plain language and subtitles. This helps individuals and their families understand the process, what to expect, and how to prepare. Multi-Language Support – Information is available in multiple languages, and interpreters are available upon request to support communication needs during assessments and consultations. Alternative Formats – Service information is available in large print, Braille, and audio upon request to support individuals with visual or reading impairments.  

12.2 Flexible Assessment and Appointment Options BrightPath Neuro offers flexible options to accommodate the needs of clients, including: Home-based and virtual assessments for clients who may experience anxiety or sensory overload in clinical settings. Extended appointment times to allow for additional processing time or to reduce stress during assessments. Break options during assessments to prevent sensory or cognitive overload. Quiet waiting areas for individuals with sensory processing difficulties.  

12.3 Individualised Support Plans Reasonable adjustments are built into individualised care plans based on the client’s specific needs. Adjustments may include the use of alternative communication tools (e.g., PECs, Makaton) during sessions. Assessment tools are modified for individuals with sensory or cognitive challenges to ensure accurate and fair outcomes. Clinicians are trained to adapt their approach based on the individual's communication style, processing speed, and comfort level.  

12.4 Staff Training and Awareness All staff receive training on providing reasonable adjustments and ensuring accessible communication. Training covers supporting individuals with cognitive, sensory, and communication difficulties. Staff are trained to recognize when reasonable adjustments are needed and how to implement them effectively. Clinicians are encouraged to ask clients directly about their communication preferences and support needs.  

12.5 Monitoring and Feedback BrightPath Neuro actively monitors the effectiveness of reasonable adjustments through: Regular feedback from clients and families. Reviewing data on service accessibility and outcomes to identify any gaps or barriers. Annual audits to assess the impact of accessibility measures and identify areas for improvement. Adjustments and improvements are made based on feedback and outcomes.  

BrightPath Neuro’s Equality, Diversity, and Human Rights Policy Alignment with CQC Key Lines of Enquiry (KLOEs) BrightPath Neuro’s Equality, Diversity, and Human Rights Policy aligns with the Care Quality Commission (CQC) Key Lines of Enquiry (KLOEs) by ensuring that equality, diversity, and human rights principles are embedded into all aspects of care delivery, organisational management, and staff practices. Below is a detailed analysis of how the policy aligns with each CQC KLOE:  

1. Safe (S) The policy meets the requirements for ensuring that individuals are protected from harm, discrimination, and abuse:

S1 – How do systems, processes, and practices keep people safe and safeguarded from abuse? The policy outlines a framework for identifying and addressing discriminatory or abusive practices. There is a zero-tolerance approach to discrimination, harassment, and victimisation. Staff are trained to recognise and report discriminatory behaviour or practices that could cause psychological harm. All incidents of discrimination, bias, or harassment are investigated under the organisation’s safeguarding and complaints procedures.

S2 – How are risks to people assessed, and how are they monitored and managed so they are supported to stay safe? The policy includes structured risk assessment processes to identify risks related to discrimination, inequality, or exclusion. Support measures, including advocacy and reasonable adjustments, are implemented to reduce risks and ensure fair treatment. Staff are trained to identify situations where discriminatory practices may place individuals at risk of psychological harm or isolation.

S3 – How does the service ensure the proper and safe use of medicines? Although not directly related to equality and diversity, the policy ensures that medication-related decisions are free from discrimination and bias. Prescribing and medication management are conducted in line with the principles of equality and fairness.

S4 – How does the provider ensure the premises and equipment are safe and that people are protected from avoidable harm? The policy includes provisions for ensuring that clinical and non-clinical environments are accessible and safe for individuals with disabilities. Physical and environmental adjustments are made to ensure equal access to facilities and equipment. Signage, pathways, and clinical areas are designed to meet the needs of individuals with sensory or mobility impairments.

S5 – What is the track record on safety? Data on equality-related complaints, discriminatory incidents, and access barriers is monitored and reported regularly. Trends in discriminatory practices or access issues are identified and addressed through targeted action plans.  

2. Effective (E) The policy meets the requirements for ensuring that equality, diversity, and human rights measures are effective and evidence-based:

E1 – Are people’s needs and choices assessed, and is care, treatment, and support delivered in line with current legislation, standards, and evidence-based guidance? The policy is aligned with the Equality Act 2010, the Human Rights Act 1998, and the Public Sector Equality Duty. Assessments and care plans are adjusted to reflect the cultural, religious, and social backgrounds of service users. Individualised care plans include reasonable adjustments to meet the specific needs of diverse groups.

E2 – How does the service ensure that staff have the skills, knowledge, and experience to deliver effective care, support, and treatment? Staff receive mandatory training on equality, diversity, and human rights. Scenario-based training is used to develop staff competence in responding to diversity-related challenges and bias. Competency in equality and diversity practice is assessed during annual performance reviews.

E3 – How are staff, teams, and services working together to deliver effective care and support? The policy outlines clear roles and responsibilities for promoting equality and diversity across teams. Multi-disciplinary team meetings incorporate discussions on equality and inclusion. Staff are trained to work collaboratively with external agencies to address systemic discrimination and inequalities.

E4 – How are people supported to live healthier lives and access care, support, and treatment? Targeted outreach programs are in place to engage minority and underrepresented groups. Psychoeducation and health promotion materials are adapted to meet the cultural and linguistic needs of diverse communities. Flexible appointment times, multi-language support, and accessible venues are provided to reduce access barriers.

E5 – How are people’s outcomes improved and sustainability of care ensured? Data on health outcomes by demographic group is monitored to identify and reduce disparities. Findings from outcome reviews are used to adjust services and care models to improve accessibility and fairness.  

3. Caring (C) The policy meets the requirements for providing care that is person-centred, respectful, and culturally competent:

C1 – How does the service ensure that people are treated with kindness, respect, and compassion, and that they are given emotional support when needed? Staff are trained in culturally sensitive communication and care practices. Gender-neutral language, culturally appropriate greetings, and respectful communication styles are encouraged. Staff receive LGBTQ+ sensitivity training to ensure that individuals feel respected and supported.

C2 – How does the service support people to express their views and be actively involved in making decisions about their care and treatment as far as possible? Service users’ communication preferences, cultural values, and religious beliefs are recorded and respected in care planning. Advocacy services are available for individuals with language barriers or additional communication needs. The policy encourages staff to actively seek feedback from underrepresented groups.

C3 – How is people’s privacy and dignity respected? The policy includes measures to protect the confidentiality of personal data, including gender identity and sexual orientation. Service users’ pronouns, names, and cultural preferences are documented and respected. Facilities include gender-neutral spaces and private areas for sensitive conversations.  

4. Responsive (R) The policy meets the requirements for ensuring that services are flexible and responsive to the diverse needs of individuals:

R1 – How do people receive personalised care that is responsive to their needs? Individualised support plans are developed based on cultural background, communication needs, and personal identity. Reasonable adjustments are made to care delivery to accommodate disabilities and diverse communication styles.

R2 – How does the service listen to and respond to complaints and concerns? An accessible online reporting system allows individuals to raise concerns about discrimination or unfair treatment. Complaints are reviewed promptly, and findings are used to adjust practices and improve equality.

R3 – How are people’s concerns and complaints listened and responded to, and used to improve the quality of care? Complaint data is monitored to identify patterns of discrimination or exclusion. Findings from complaints are shared with staff and used to update training and policies.  

5. Well-Led (W) The policy meets the requirements for ensuring that equality, diversity, and human rights governance and leadership are strong and effective:

W1 – Is there a clear vision and credible strategy to deliver high-quality care and support? The policy defines clear leadership and accountability for equality and diversity. The Equality, Diversity, and Human Rights Lead (Tianny Brown) is responsible for monitoring performance and providing strategic oversight. W2 – Is there a clear governance framework that ensures quality, performance, and risk are managed effectively? The policy is integrated into BrightPath Neuro’s overall governance framework. Equality and diversity compliance data is reported quarterly to the senior leadership team.

W3 – Are the leaders aware of the risks and challenges, and are they acting to address them? Data on health disparities, access barriers, and discrimination incidents is monitored and reviewed regularly. Action plans are developed to address identified challenges and improve outcomes for diverse groups. W4 – How does the service continuously learn, improve, and innovate? Findings from service user feedback, audits, and complaints are used to update policies and practices. Staff receive regular training updates to reflect changes in equality and diversity best practices.

W5 – How does the service work in partnership with other agencies? BrightPath Neuro collaborates with NHS trusts, local authorities, and advocacy groups to address systemic inequalities. The policy outlines joint working arrangements with policymakers to influence national equality strategies.  

Summary of CQC KLOE Compliance   KLOE Level of Compliance Comments Safe (S) Fully compliant Strong framework for identifying and managing risks related to discrimination and bias. Effective (E) Fully compliant Staff training and multi-agency collaboration enhance effectiveness. Caring (C) Fully compliant Culturally sensitive and person-centred approach to care. Responsive (R) Fully compliant Flexible service delivery tailored to diverse needs. Well-Led (W) Fully compliant Strong leadership and governance for equality and diversity.

Conclusion BrightPath Neuro’s Equality, Diversity, and Human Rights Policy meets all CQC KLOE requirements and reflects national best practices and legal standards. The policy ensures that equality, diversity, and human rights principles are embedded into all areas of service delivery and governance.        

13. Policy Governance Policy Lead: Paul Davis, Director of Operations Equality, Diversity, and Human Rights Lead: Tianny Brown Date Created: 21 March 2025 Next Review Date: 21 March 2026

Your satisfaction is important to us. If you're not happy with any part of our service, please contact us directly. We will listen to your concerns and work with you to resolve any issues quickly and professionally. You can also fill out our complaints form and read our full Complaints Policy here..

 👉 Submit a Complaint online now

Complaints Policy

1. Introduction Brightpath Neuro is committed to providing high-quality neurodiversity and mental health services. We value all feedback, including complaints, as they help us improve our services and ensure that we meet the highest standards of care and professionalism. We aim to handle all complaints fairly, sensitively, and promptly, ensuring that any issues raised are addressed effectively and in line with regulatory and professional standards.

2. Scope This policy applies to: Clients using Brightpath Neuro’s services. Parents or guardians of clients (where applicable). Staff members and third parties involved in the provision of our services.

3. Purpose The purpose of this policy is to: Provide a clear process for making a complaint. Ensure that complaints are handled fairly, consistently, and promptly. Identify areas for improvement based on feedback received. Ensure that all complaints are treated with respect and confidentiality.

4. Definition of a Complaint A complaint is defined as any expression of dissatisfaction with: The quality of service provided by Brightpath Neuro. The conduct or behavior of staff members. The content, accuracy, or outcome of an assessment, report, or service. Communication issues or delays in response.

5. How to Make a Complaint We encourage you to raise any concerns at the earliest opportunity so that we can address them quickly and effectively. Complaints can be made in the following ways: By Email: [email protected] By Phone: [Insert Business Phone Number] In Writing: [Insert Business Address] Please include the following details when making a complaint: Your full name and contact details. The nature of the complaint (including relevant dates and locations). The names of any staff involved (if known). Any supporting documents or evidence (if applicable).

6. Acknowledgement of Complaints We will acknowledge receipt of your complaint within 2 working days. We will provide the name of the person handling your complaint and an estimated timeframe for resolving the issue.

7. Complaint Investigation Process Step 1 – Initial Review The complaint will be assigned to a senior member of the team for investigation. The investigator will review the details and speak to any staff involved. Step 2 – Investigation We aim to complete the investigation within 10 working days. If the investigation requires more time, you will be informed of the reason for the delay and the new estimated completion date. Step 3 – Outcome and Resolution A written response will be provided detailing: The findings of the investigation. Any corrective actions or changes implemented. Any further steps you may wish to take if you remain dissatisfied. If the complaint is upheld, appropriate remedial action will be taken to prevent recurrence.

8. Escalation Process If you are not satisfied with the outcome of your complaint, you can request a review of the decision by the Director of Clinical Services. A request for escalation should be made within 5 working days of receiving the initial outcome. The review will be conducted within 10 working days, and a final decision will be communicated in writing. If you are still dissatisfied after the escalation process, you may contact the relevant regulatory body: Contact Information for Regulatory Bodies: Care Quality Commission (CQC): Website: www.cqc.org.uk Phone: 03000 616161 Information Commissioner’s Office (ICO): Website: www.ico.org.uk Phone: 0303 123 1113

9. Confidentiality and Data Protection All complaints will be treated with strict confidentiality. Information will only be shared with those directly involved in the complaint’s resolution. All data related to complaints will be handled in accordance with our Privacy Policy and the UK General Data Protection Regulation (UK GDPR).

10. Monitoring and Review All complaints are logged and monitored to identify patterns and areas for improvement. This policy is reviewed annually to ensure compliance with legal and regulatory standards and to reflect any changes in service delivery.

11. Responsibilities Staff Responsibilities: All staff are responsible for cooperating with investigations and supporting the resolution of complaints. Management Responsibilities: Senior management is responsible for ensuring that complaints are handled in line with this policy and that any necessary changes are implemented.

12. Policy Review This policy will be reviewed annually or earlier if required by regulatory changes or internal feedback.

1. Introduction BrightPath Neuro is committed to providing a high standard of care through effective governance structures, systems, and processes. Governance is the framework through which BrightPath Neuro ensures that all aspects of service delivery, operational management, and staff oversight are well-led, safe, effective, and responsive to the needs of service users.   This policy outlines the governance framework at BrightPath Neuro, defining how the organisation is managed and governed to promote accountability, transparency, and continuous improvement. It ensures that the organisation meets all legal, ethical, and professional standards while delivering high-quality, person-centred care.  

Governance at BrightPath Neuro reflects our commitment to the Care Quality Commission’s (CQC) key lines of enquiry (KLOEs) and the fundamental standards of care. Through strong leadership, clear roles and responsibilities, and a culture of learning and improvement, BrightPath Neuro ensures that services are consistently safe, effective, and responsive to the needs of service users.  

2. Purpose The purpose of this policy is to: Establish a governance framework that supports high standards of care and service delivery. Define clear roles, responsibilities, and accountability for governance practices. Ensure compliance with statutory and regulatory requirements, including the General Data Protection Regulation (GDPR) and the Health and Social Care Act 2008. Foster a culture of openness, transparency, and continuous improvement. Provide a system for monitoring and improving the quality and safety of services. Securely manage and maintain accurate and complete records related to service users and staff employment. By adhering to this policy, BrightPath Neuro ensures that governance is embedded into all aspects of service delivery and organisational management.   3. Scope This policy applies to: All staff, including permanent, temporary, and agency workers. All volunteers and contractors working on behalf of BrightPath Neuro. All services delivered by BrightPath Neuro, including clinical assessments, therapeutic interventions, and care planning. All operational areas, including information management, staff oversight, risk management, and performance monitoring. The governance framework applies to all settings where BrightPath Neuro operates, including: Clinical environments Virtual platforms External partnerships and collaborations   4. Legislative and Regulatory Framework BrightPath Neuro’s governance framework is aligned with the following legal and regulatory requirements:     Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 Regulation 17: Requires providers to assess, monitor, and improve the quality and safety of services. Regulation 20: Requires providers to uphold the Duty of Candour. General Data Protection Regulation (GDPR) Governs the processing, storage, and sharing of personal data, ensuring the confidentiality and security of service user and staff records. Data Protection Act 2018 Sets out the requirements for processing personal data in the UK. Care Quality Commission (CQC) Guidance Provides a framework for ensuring services are safe, effective, caring, responsive, and well-led. Equality Act 2010 Protects individuals from discrimination based on protected characteristics.   5. Core Principles of Governance BrightPath Neuro’s governance framework is based on the following principles:  

1. Leadership and Accountability Clear leadership structure with defined roles and responsibilities. Senior management is accountable for service delivery and clinical standards. Staff are supported to deliver care in line with BrightPath Neuro’s values and best practice guidelines.

2. Quality and Safety Services are delivered in a manner that minimises risks and protects service users from harm. Systems are in place to assess, monitor, and improve the quality and safety of services.

3. Person-Centred Care Services are designed around the needs, preferences, and feedback of service users. Feedback from service users is actively sought and used to improve care delivery.

4. Openness and Transparency BrightPath Neuro promotes a culture of honesty, integrity, and openness. Duty of Candour requirements are followed, including informing service users and families about incidents and lessons learned.

5. Continuous Improvement Governance processes support learning from incidents and audits. Staff are encouraged to engage in reflective practice and quality improvement initiatives.  

6. Governance Structure BrightPath Neuro’s governance structure defines clear roles and responsibilities at all levels of the organisation to ensure effective oversight and accountability.   Organisational Structure

7. Responsibilities Clinical Director – Steven Davis (Governance Lead) Oversees the implementation of the governance framework. Ensures compliance with statutory and regulatory requirements. Monitors service performance and leads quality improvement initiatives. Provides clinical leadership and strategic direction for the organisation. Promotes a culture of accountability, learning, and continuous improvement. Ensures that clinical practices align with evidence-based guidelines and best practice standards.   Deputy Clinical Director – Melanie Kennett Supports the Clinical Director in implementing clinical governance and ensuring high standards of care. Oversees clinical staff, ensuring they follow clinical guidelines and best practices. Assists in monitoring service performance and identifying areas for improvement. Manages day-to-day clinical operations and provides clinical supervision to staff. Ensures effective management of clinical risks and incidents.   Marketing Director – Andy Forsyth Develops and implements the organisation’s marketing strategy. Oversees communication and outreach to external stakeholders and potential clients. Ensures that marketing activities align with BrightPath Neuro’s vision and values. Monitors the effectiveness of marketing campaigns and adjusts strategies as needed. Promotes BrightPath Neuro’s services and enhances the organisation’s public profile.   Customer Service Manager and Policy Lead – Paul Davis Responsible for ensuring that governance policies and procedures are up to date and effective. Provides strategic oversight and ensures alignment with the organisation’s vision and goals. Oversees customer service operations to ensure high levels of client satisfaction. Manages client feedback, ensuring concerns and complaints are addressed promptly and effectively. Ensures all policies meet regulatory and professional standards. Leads the implementation of feedback and quality improvement initiatives.   Social Media Manager – Tom White Manages and oversees the organisation’s social media presence. Develops content strategies to promote BrightPath Neuro’s services and values. Engages with followers and responds to inquiries and comments. Monitors social media analytics and adjusts strategies to improve engagement and outreach. Ensures that all content reflects the organisation’s professional standards and tone of voice.   Non-Medical Prescriber (NMP) – Terri Berkeley-Corner Provides prescribing services within the scope of professional practice and national guidelines. Conducts medication reviews and monitors treatment outcomes. Ensures safe and effective prescribing in line with regulatory requirements. Works collaboratively with the clinical team to provide integrated care. Provides guidance and training to staff on medication management.   Assistant Psychologist – Tianny Brown Supports the clinical team in delivering psychological assessments and interventions. Conducts research and collects data to support clinical decision-making. Develops and implements therapeutic strategies under supervision. Provides psychoeducation and support to service users and their families. Contributes to the evaluation of treatment outcomes and service performance.  

8. Feedback and Service Improvement BrightPath Neuro actively seeks feedback from: Service users and their families Staff and contractors External stakeholders (e.g., CQC, NHS partners)   Methods for Feedback: Annual service user surveys Incident reports and complaints Staff supervision and appraisal sessions Feedback forms on the BrightPath Neuro website Feedback is reviewed regularly, and action plans are developed to address issues and improve services.   9. Risk Management and Incident Reporting BrightPath Neuro has a structured process for managing risks: Identify: Staff are encouraged to report risks and incidents. Assess: Risks are assessed based on severity and likelihood. Mitigate: Actions are taken to reduce risks and prevent recurrence. Monitor: Risks and incidents are reviewed regularly to identify patterns and improvements.   10. Records Management BrightPath Neuro securely manages and maintains records in line with the Data Protection Act 2018 and GDPR: Records are stored securely with access controls. Data is encrypted where necessary. Retention and disposal schedules are followed.   11. Monitoring and Review This policy will be reviewed annually or following significant incidents, regulatory changes, or organisational restructuring. Feedback from staff, service users, and stakeholders will be used to update the policy.  

12. Quality, Diversity, and Inclusion BrightPath Neuro is committed to embedding diversity, equity, and inclusion across all aspects of service delivery, governance, and operational management. Our approach reflects our commitment to ISO 9001 quality standards and the promotion of best practices aligned with NHS guidelines, NICE standards, and regulatory requirements. We actively seek to reduce barriers to care, address health inequalities, and provide culturally competent and person-centred services to underrepresented groups, including minority ethnic communities and LGBTQ+ individuals.  

13. Quality and Compliance with ISO 9001 BrightPath Neuro is accredited to the ISO 9001 Quality Management System (QMS), which provides a structured framework for consistent service delivery and continuous improvement. The ISO 9001 framework ensures that all processes are systematically documented, monitored, and reviewed to enhance quality, safety, and service user experience. The key elements of our ISO 9001 framework include: Leadership and Governance – Ensuring that senior leadership drives a culture of quality and accountability. Risk Management – Implementing a structured approach to identifying, assessing, mitigating, and monitoring risks across all operational areas. Performance Monitoring – Regular tracking of key performance indicators (KPIs) to evaluate clinical outcomes, service efficiency, and user satisfaction. Continuous Improvement – Establishing a cycle of quality improvement through regular audits, feedback analysis, and corrective actions. Staff Training and Development – Ensuring that all staff are trained in quality standards, clinical governance, and professional best practice.  

13.1 Self-Assessment and Annual Quality Improvement To maintain ISO 9001 accreditation, BrightPath Neuro conducts: Annual self-assessment reports to evaluate compliance with ISO 9001 standards. Quarterly performance reviews to monitor clinical and operational outcomes. Internal and external audits to identify gaps and opportunities for improvement. Service user feedback analysis to measure satisfaction and identify service improvements. Action Plans – Findings from self-assessment and audits are used to create detailed action plans to improve service quality and efficiency. Outcomes and improvements from these processes are reported to the senior leadership team and incorporated into the organisation’s annual Quality Improvement Report.  

14. Health and Safety Compliance BrightPath Neuro is committed to providing a safe working environment for both service users and staff, in line with the Health and Safety at Work Act 1974 and relevant Health and Safety Executive (HSE) guidelines. Our health and safety framework includes: Risk Assessments – Regular risk assessments conducted in clinical and non-clinical environments to identify hazards and implement control measures. Incident Reporting and Investigation – Clear procedures for reporting, investigating, and resolving health and safety incidents. Training and Awareness – All staff receive mandatory health and safety training, including fire safety, infection control, and manual handling. Environmental Controls – Monitoring of clinical spaces to ensure adequate ventilation, hygiene standards, and infection control protocols. Personal Protective Equipment (PPE) – Provision of appropriate PPE to staff and service users where required. Mental Health and Wellbeing – Ensuring staff have access to mental health and wellbeing support, including occupational health services.  

15. Environmental Management and Sustainability BrightPath Neuro is committed to reducing its environmental impact and promoting sustainable practices across all areas of operation. Our environmental management strategy aligns with ISO 14001 standards and includes: Energy Efficiency – Implementing energy-saving measures, including LED lighting, smart meters, and low-energy appliances. Waste Reduction – Reducing waste through recycling, reduced paper use, and sustainable procurement practices. Carbon Footprint Monitoring – Tracking and reducing our carbon footprint through transport policies and remote working options. Clinical Waste Management – Safe and compliant disposal of clinical waste in line with NHS and environmental guidelines. Digital Transition – Reducing paper-based records and communication through the use of secure digital systems.  

16. Best Practice and Clinical Standards BrightPath Neuro follows best practice guidelines from the National Institute for Health and Care Excellence (NICE) and the NHS to ensure that all clinical services meet national standards. This includes: NICE Guidelines for ADHD and ASC – Assessments and interventions for ADHD and autism are delivered according to NICE guidelines. Prescribing Practices – Medication reviews and prescribing practices follow national and local NHS standards. Care Planning – Individualised care plans are developed in collaboration with service users and families to reflect best practice in person-centred care. Safeguarding – Safeguarding policies and procedures are based on NHS and local authority guidelines to protect vulnerable individuals. Clinical Supervision and Peer Review – Clinical staff participate in regular supervision and peer review sessions to reflect on practice and improve clinical decision-making.  

17. Governance Structure and Oversight To maintain accountability and oversight, BrightPath Neuro has established a clear governance structure that aligns with ISO 9001 requirements: Role Responsibility Clinical Director – Steven Davis Oversees clinical governance, compliance, and quality improvement initiatives. Ensures alignment with NICE and NHS standards. Deputy Clinical Director – Melanie Kennett Manages day-to-day clinical operations and ensures staff compliance with clinical guidelines. Marketing Director – Andy Forsyth Ensures external communications reflect professional standards and values. Customer Service Manager – Paul Davis Ensures service user feedback is acted upon to improve quality and satisfaction. Social Media Manager – Tom White Ensures content reflects BrightPath Neuro’s professional tone and values. Non-Medical Prescriber – Terri Berkeley-Corner Ensures medication management practices align with national standards and NICE guidelines. Assistant Psychologist – Tianny Brown Supports clinical service delivery through assessments and psychoeducation.  

18. Feedback and Learning Culture BrightPath Neuro actively promotes a learning culture where staff are encouraged to engage in reflective practice and contribute to quality improvement. Feedback is gathered through: Annual Service User Surveys – Direct feedback from service users and families. Incident and Complaint Reporting – All incidents and complaints are investigated, and learning points are shared with staff. Staff Supervision and Performance Reviews – Regular reviews to evaluate staff performance and identify training needs. Quality Improvement Meetings – Monthly governance meetings to review service performance, feedback, and action plans. Learning from incidents and feedback is used to create action plans and improve service delivery.  

19. Risk Management and Incident Reporting BrightPath Neuro maintains a proactive approach to risk management, aligned with ISO 9001 and NHS best practices: Identify – Staff are trained to identify risks and potential service failures. Assess – Risks are assessed for severity and likelihood using a structured risk matrix. Mitigate – Immediate action is taken to reduce or eliminate risks. Monitor – Risk assessments are reviewed and updated regularly. Review – Lessons from incidents and near misses are shared with staff and incorporated into governance reviews.  

20. Records Management and Data Protection BrightPath Neuro maintains high standards of data security and confidentiality in line with GDPR and ISO 9001 requirements: Secure Storage – All service user and staff records are stored securely with controlled access. Data Protection Training – All staff receive training in GDPR and data security. Retention and Disposal – Records are retained and disposed of in line with national guidelines. Encryption – Data is encrypted to protect against unauthorised access.  

21. Monitoring and Continuous Improvement BrightPath Neuro is committed to continuous improvement through: Annual Quality Improvement Plan – Created from findings of audits, self-assessments, and service user feedback. Clinical Audits – Regular clinical audits to assess the quality and consistency of service delivery. Benchmarking – Comparing performance with national and regional standards to identify areas for improvement. Annual ISO 9001 Review – External review of compliance with ISO 9001 standards. Action Plans – Detailed plans to address gaps and implement improvements.   BrightPath Neuro’s Governance Policy Alignment with CQC Key Lines of Enquiry (KLOEs) BrightPath Neuro’s Governance Policy aligns with the Care Quality Commission (CQC) Key Lines of Enquiry (KLOEs) by ensuring that governance structures, processes, and systems are in place to deliver consistently safe, effective, caring, responsive, and well-led services. Below is a detailed analysis of how the policy aligns with each CQC KLOE:  

1. Safe (S) The policy meets the requirements for ensuring that services are delivered in a manner that protects individuals from harm, abuse, and neglect while minimising risks:

S1 – How do systems, processes, and practices keep people safe and safeguarded from abuse? Clear safeguarding protocols are outlined, including processes for identifying, reporting, and managing safeguarding incidents. The Duty of Candour is embedded into governance practices, ensuring that any incidents of harm are openly reported and addressed. The governance framework includes a structured approach to reviewing and learning from incidents. Systems are in place to monitor clinical risks and ensure that safety measures are promptly implemented.

S2 – How are risks to people assessed, and how are they monitored and managed so they are supported to stay safe? Risk assessment is embedded into clinical governance, operational oversight, and staff performance monitoring. Risks are assessed based on severity and likelihood, and mitigation strategies are implemented where necessary. Risks related to medication, safeguarding, and environmental factors are identified and addressed through regular audits and reviews.

S3 – How does the service ensure the proper and safe use of medicines? Prescribing practices are managed by qualified healthcare professionals, including a Non-Medical Prescriber. Medication reviews are conducted regularly to monitor effectiveness and safety. Medication management is aligned with NICE guidelines and national standards.

S4 – How does the provider ensure the premises and equipment are safe and that people are protected from avoidable harm? Regular health and safety audits are conducted to monitor the safety of clinical environments. Incident reporting and environmental risk assessments are integrated into the governance framework. Infection control measures are monitored and improved through regular staff training and compliance checks.

S5 – What is the track record on safety? Data on clinical incidents, safeguarding concerns, and environmental hazards is reviewed regularly by the governance lead. Findings from safety reviews are shared with staff through governance meetings and feedback sessions. Action plans are created to address identified risks and improve safety outcomes.  

2. Effective (E) The policy meets the requirements for ensuring that services are delivered in line with national guidelines and evidence-based practices:

E1 – Are people’s needs and choices assessed, and is care, treatment, and support delivered in line with current legislation, standards, and evidence-based guidance? Governance structures are aligned with national guidelines, including NICE and CQC standards. Individualised care plans are developed based on clinical assessments and service user feedback. The governance framework includes monitoring of clinical outcomes to ensure effectiveness and compliance.

E2 – How does the service ensure that staff have the skills, knowledge, and experience to deliver effective care, support, and treatment? Staff receive training in clinical governance, safeguarding, health and safety, and quality improvement. Competence is assessed through regular supervision, audits, and staff reviews. Professional development is integrated into the governance framework to maintain high clinical standards.

E3 – How are staff, teams, and services working together to deliver effective care and support? The governance framework supports multi-disciplinary working across clinical and operational teams. Information sharing protocols are in place to ensure consistent care planning and delivery. Feedback from staff and service users is used to improve teamwork and communication.

E4 – How are people supported to live healthier lives and access care, support, and treatment? The governance framework includes strategies for improving health outcomes for service users. Psychoeducation and health promotion programs are monitored and evaluated through governance processes. Action plans are created to address health inequalities and improve access to services.

E5 – How are people’s outcomes improved and sustainability of care ensured? Key performance indicators (KPIs) for clinical and operational outcomes are tracked through the governance structure. Outcome data is reviewed regularly to identify trends and areas for improvement. Findings from audits and reviews are used to update care models and improve service delivery.  

3. Caring (C) The policy meets the requirements for ensuring that care is delivered with compassion and respect:

C1 – How does the service ensure that people are treated with kindness, respect, and compassion, and that they are given emotional support when needed? The governance framework includes monitoring of staff performance related to communication and empathy. Service user feedback is sought regularly to assess the quality of interpersonal interactions. Staff receive training on providing compassionate, person-centred care.

C2 – How does the service support people to express their views and be actively involved in making decisions about their care and treatment as far as possible? Service user involvement is a key element of the governance framework. Feedback from service users is used to adjust care plans and improve service delivery. Reasonable adjustments are made to support communication and decision-making. C3 – How is people’s privacy and dignity respected? The governance framework includes clear standards for protecting confidentiality and privacy. Data protection is managed in line with GDPR requirements. Staff are trained to maintain professional boundaries and respect service user dignity.  

4. Responsive (R) The policy meets the requirements for ensuring that services are flexible, personalised, and responsive to the needs of service users:

R1 – How do people receive personalised care that is responsive to their needs? Individualised care plans are created based on service user needs and feedback. The governance framework supports reasonable adjustments and service modifications to accommodate diverse needs. Staff are trained to adapt care delivery based on individual preferences and clinical requirements.

R2 – How does the service listen to and respond to complaints and concerns? The governance framework includes a structured process for managing complaints. Complaints are logged, reviewed, and used to improve service quality. Findings from complaints are shared with staff to promote learning and improvement.

R3 – How are people’s concerns and complaints listened and responded to, and used to improve the quality of care? Complaints and incident data are reviewed quarterly through the governance framework. Action plans are developed to address issues raised through complaints and service user feedback. Trends in complaints are analysed to identify systemic issues and areas for improvement.  

5. Well-Led (W) The policy meets the requirements for ensuring that the organisation is well-led, with clear governance structures and strategic oversight:

W1 – Is there a clear vision and credible strategy to deliver high-quality care and support? BrightPath Neuro’s governance framework reflects the organisation’s strategic priorities and quality objectives. Leadership structures and responsibilities are clearly defined. The governance framework ensures alignment with national standards and local requirements.

W2 – Is there a clear governance framework that ensures quality, performance, and risk are managed effectively? The governance framework includes monitoring, auditing, and reporting of clinical and operational performance. Findings from audits and reviews are presented to the senior leadership team. Risk management strategies are integrated into governance processes.

W3 – Are the leaders aware of the risks and challenges, and are they acting to address them? Senior leadership regularly reviews clinical and operational risks. Action plans are created and monitored to address identified risks and challenges. Staff are encouraged to report risks and concerns through a structured reporting process.

W4 – How does the service continuously learn, improve, and innovate? Continuous improvement is embedded into the governance framework through ISO 9001 compliance. Findings from self-assessments and audits are used to create action plans. Staff are encouraged to contribute to improvement initiatives through governance meetings.

W5 – How does the service work in partnership with other agencies? The governance framework includes joint working with NHS partners, local authorities, and third-sector organisations. Information sharing and collaboration protocols are defined in governance processes. Feedback from external partners is used to improve care delivery.        

12. Policy Governance Governance Lead: Steven Davis Policy Lead: Paul Davis Date Created: 21 March 2025 Next Review Date: 21 March 2026    

1. Introduction BrightPath Neuro is committed to maintaining a safe, clean, and hygienic environment to prevent and control the spread of infections. This policy provides a framework for all staff, volunteers, and stakeholders to implement effective infection prevention and control (IPC) measures.   Infection prevention and control is critical to safeguarding the health and well-being of service users, staff, and visitors. By adhering to robust IPC practices, BrightPath Neuro ensures the highest standards of safety and care across all settings, including clinical environments, virtual platforms, and external engagements.   This policy reflects BrightPath Neuro’s commitment to providing safe, effective, and person-centred care while meeting legal, regulatory, and professional standards.  

2. Purpose The purpose of this policy is to: Outline the responsibilities and practices for infection prevention and control. Ensure compliance with legislative and regulatory requirements related to IPC. Minimise the risk of infection to service users, staff, and stakeholders. Promote a culture of awareness and vigilance regarding hygiene and cleanliness. Ensure that infection prevention and control are embedded into the governance framework of BrightPath Neuro.   By adhering to this policy, BrightPath Neuro demonstrates its commitment to creating a safe and healthy environment for all.  

3. Scope This policy applies to: All employees, contractors, volunteers, service users, and stakeholders of BrightPath Neuro. All aspects of infection prevention and control, including: Hygiene practices and standards. Management of infectious diseases. Safe handling of waste and hazardous materials. Cleaning, disinfection, and sterilisation procedures. Staff vaccination protocols.   The policy applies across all service settings, including: Clinical facilities. Virtual consultations. External partnerships and collaborations.  

4. Legislative Framework This policy aligns with the following laws and guidelines:   Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 Regulation 12 requires providers to ensure safe care by preventing and controlling infections. The Code of Practice on the prevention and control of infections, issued under the Act, provides a framework for effective IPC. The Public Health (Control of Disease) Act 1984 Provides legal powers for managing and controlling infectious diseases.   The Health and Safety at Work etc. Act 1974 Places a duty on employers to protect staff, service users, and others from health risks, including infections.   The Equality Act 2010 Ensures infection control measures are applied equitably and without discrimination. National Institute for Health and Care Excellence (NICE) Guidelines   Provides evidence-based recommendations for infection prevention and control practices.   Compliance with these frameworks ensures that BrightPath Neuro meets its legal and ethical obligations to minimise infection risks.  

5. Definitions Infection The invasion and multiplication of harmful microorganisms in the body, which may cause illness.   Infection Prevention and Control (IPC) Measures implemented to reduce the risk of infection and stop its spread.   Infectious Diseases Illnesses caused by pathogens such as bacteria, viruses, fungi, or parasites, which can be transmitted from person to person or through the environment.

6. Principles of Infection Prevention and Control BrightPath Neuro follows the core principles of IPC:   1. Hygiene and Cleanliness Adhering to hand hygiene protocols and ensuring clean workspaces. Providing handwashing facilities and hand sanitisers in all clinical areas. Ensuring that personal hygiene is maintained by all staff and service users. 2. Safe Practices Implementing precautions such as wearing appropriate Personal Protective Equipment (PPE). Using safe disposal methods for clinical waste and hazardous materials. 3. Education and Training Providing regular training to staff on IPC measures and infectious disease management. Updating staff on changes to legislation and best practices. 4. Risk Assessment Conducting regular risk assessments to identify and mitigate infection risks. Tailoring risk assessments to the specific needs and vulnerabilities of service users. 5. Monitoring and Compliance Ensuring adherence to IPC guidelines through audits and reviews. Monitoring staff compliance and providing feedback.

7. Responsibilities Infection Prevention and Control Lead – Melanie Kennett   Oversees the implementation of the infection control framework. Ensures compliance with statutory and regulatory requirements. Provides training and guidance on infection control practices. Investigates and manages incidents related to infection control. Leads infection control audits and quality improvement initiatives.   Policy Lead – Paul Davis Ensures that infection control policies and procedures are regularly reviewed and updated. Provides strategic oversight and ensures alignment with the organisational vision and regulatory standards. Ensures that staff are informed of changes to infection control protocols.   All Staff Maintain hygiene standards, including hand hygiene and personal cleanliness. Use PPE as required for the task. Report any IPC breaches, incidents, or potential outbreaks to the IPC Lead. Follow IPC guidelines and attend regular training sessions.  

8. Key Infection Control Practices

1. Hand Hygiene Wash hands frequently with soap and water or use alcohol-based hand sanitisers. Ensure handwashing facilities are available and accessible.

2. Personal Protective Equipment (PPE) PPE includes gloves, masks, gowns, and eye protection. PPE should be worn based on the task and exposure risk. Dispose of PPE safely after use in designated waste containers.

3. Cleaning and Disinfection Clean and disinfect high-touch surfaces, equipment, and clinical areas regularly. Use cleaning products that meet regulatory standards.

4. Waste Management Dispose of clinical waste, such as sharps and contaminated materials, in designated containers. Follow local authority guidelines for waste disposal.

5. Infectious Disease Management Isolate individuals suspected or confirmed to have infectious diseases. Follow public health guidelines for outbreak management. Notify local health authorities when required by law.  

9. Handling Infectious Disease Outbreaks BrightPath Neuro has a comprehensive plan for managing infectious disease outbreaks, including:   Identifying Cases: Monitoring for signs and symptoms of infectious diseases. Isolating Cases: Implementing isolation protocols to prevent transmission. Notifying Authorities: Reporting outbreaks to local health authorities. Communication: Keeping staff, service users, and stakeholders informed. Follow-Up: Reviewing outbreak responses to improve future practices.  

10. Staff Vaccination Protocols Staff are encouraged to stay up to date with vaccinations, including: COVID-19 Influenza Hepatitis B Staff vaccination records are securely maintained. Staff with symptoms of infectious diseases are required to refrain from work until cleared by a healthcare professional.  

11. COVID-19 Protocols Staff have access to appropriate PPE, including masks and gloves. Social distancing measures are implemented where appropriate. Regular cleaning and disinfection of high-touch surfaces. Staff displaying symptoms of COVID-19 must follow self-isolation protocols. Staff are supported to access COVID-19 testing when required.  

12. Reporting Concerns If an IPC concern arises, staff should: Identify the Issue – Document the incident and any potential risks. Report to the IPC Lead – Contact Melanie Kennett directly. Document the Concern – Record all relevant details, including date, time, and location, in the incident log. Escalate if Necessary – Serious incidents should be escalated to public health authorities.  

13. Monitoring and Review This policy will be reviewed annually or in response to legislative updates, significant incidents, or organisational changes. Feedback from staff, service users, and stakeholders will inform updates to ensure the policy remains effective.  

15. Compliance with ISO 9001 and NHS Best Practices BrightPath Neuro’s Infection Prevention and Control (IPC) policy is aligned with ISO 9001 Quality Management Standards and incorporates evidence-based guidelines from the National Institute for Health and Care Excellence (NICE) and NHS best practices. This ensures that all infection control measures are systematically implemented, monitored, and continuously improved to maintain the highest standards of care and safety.  

15.1 ISO 9001 Integration in IPC Practices BrightPath Neuro’s compliance with ISO 9001 ensures that infection control measures are embedded into the wider governance framework, with a focus on continuous improvement and accountability. The key aspects of ISO 9001 applied to IPC include: Documented Procedures: All infection control processes are clearly documented and reviewed regularly. Risk-Based Approach: Infection control risks are identified, assessed, and addressed using a structured framework. Performance Monitoring: Infection control compliance is tracked through regular audits and staff performance reviews. Corrective Action and Continuous Improvement: Findings from audits and feedback are used to develop action plans and improve infection control measures. As part of the ISO 9001 framework, BrightPath Neuro conducts annual self-assessments to evaluate IPC performance and identify opportunities for improvement. Any deficiencies are addressed through targeted training, revised protocols, and updated policies.  

15.2 NHS and NICE Best Practice Alignment BrightPath Neuro follows the latest NHS and NICE guidelines on infection prevention and control to ensure that all measures reflect national standards and evidence-based practices. Key areas of alignment include: Hand Hygiene: Compliance with the World Health Organisation (WHO) "5 Moments for Hand Hygiene" framework. Personal Protective Equipment (PPE): Ensuring the appropriate use of PPE based on NHS and NICE standards for different levels of infection risk. Cleaning and Disinfection: Following NHS cleaning specifications for healthcare environments, including high-touch areas and clinical equipment. Outbreak Management: Aligning with NHS and local health authority protocols for managing outbreaks of infectious diseases. BrightPath Neuro also ensures that all infection control measures are regularly updated to reflect changes in NHS and NICE guidelines.  

15.3 Environmental Health and Sustainability BrightPath Neuro’s commitment to environmental sustainability extends to infection control practices, including: Eco-Friendly Cleaning Products: Use of non-toxic, biodegradable cleaning agents that meet infection control standards. Waste Management: Ensuring that clinical and non-clinical waste disposal follows environmental guidelines and reduces landfill impact. Reducing Single-Use Plastics: Transitioning to reusable PPE where appropriate and feasible without compromising safety. Water and Energy Efficiency: Reducing water and energy consumption through efficient cleaning and sterilisation processes.  

15.4 Self-Assessment and Continuous Quality Improvement BrightPath Neuro conducts annual self-assessments and quality reviews to evaluate the effectiveness of infection control measures, in line with ISO 9001 requirements: Quarterly Audits: Infection control practices are audited every three months to identify gaps and ensure compliance. Feedback from Staff and Service Users: Service users and staff are encouraged to provide feedback on IPC measures through surveys and direct reporting. Performance Data Analysis: Data from incident reports, staff compliance reviews, and service user feedback is analysed to identify trends and areas for improvement. Action Plans: Findings from audits and self-assessments are used to develop corrective action plans and adjust training, protocols, and procedures as needed.

15.5 Staff Training and Competence BrightPath Neuro provides comprehensive training to all staff on infection control practices and standards. Training includes: Annual IPC Training: Mandatory training sessions for all clinical and non-clinical staff on infection control protocols. Scenario-Based Learning: Training in handling infectious disease outbreaks, PPE use, and cleaning protocols. Competence Assessment: Staff competency in IPC is assessed annually as part of the ISO 9001 quality review process. Tailored Training: Additional training provided for staff in high-risk roles or settings.   15.6 Monitoring and Reporting BrightPath Neuro’s ISO 9001 framework includes a structured approach to monitoring and reporting on infection control performance: Incident Reporting: All infection control breaches and incidents are reported and reviewed within 24 hours. Real-Time Monitoring: Compliance with hand hygiene, PPE use, and cleaning protocols is monitored through spot checks and audits. Annual IPC Report: An annual report on infection control performance, including findings from audits, self-assessments, and feedback, is produced and reviewed by the senior leadership team. Regulatory Reporting: Any serious incidents or outbreaks are reported to relevant health authorities in line with statutory requirements.  

16. Governance and Leadership for IPC BrightPath Neuro’s infection control governance structure aligns with ISO 9001 and best practices for leadership and accountability: Role Responsibility Infection Prevention and Control Lead – Melanie Kennett Leads all IPC measures, training, and audits; ensures compliance with ISO 9001 and NICE guidelines. Clinical Director – Steven Davis Provides strategic oversight for IPC, ensuring alignment with governance and clinical standards. Deputy Clinical Director – Melanie Kennett Manages day-to-day implementation of IPC measures; ensures staff compliance and competence. Policy Lead – Paul Davis Ensures that IPC policies are regularly reviewed and reflect current guidelines and best practice. Health and Safety Lead Monitors health and safety risks related to infection control; ensures staff adherence to health and safety regulations. All Staff Responsible for adhering to IPC protocols, reporting breaches, and participating in training.

17. Performance and Continuous Improvement Performance in infection prevention and control is tracked through: Audit Compliance Rates: Monitoring adherence to hand hygiene, PPE use, and cleaning protocols. Incident Reporting: Tracking and analysing incident reports to identify trends and gaps. Service User Feedback: Regular surveys to assess service user confidence in IPC measures. Training Completion Rates: Monitoring staff participation and completion of training. Improvement Metrics: Evaluation of corrective action outcomes and overall infection rates.  

18. Conclusion This Infection Prevention and Control Policy demonstrates BrightPath Neuro’s commitment to maintaining the highest standards of cleanliness, safety, and infection control. By embedding ISO 9001 principles, NHS and NICE best practices, and a structured framework for monitoring and improvement, BrightPath Neuro ensures a safe and responsive environment for service users, staff, and stakeholders.   This policy will be reviewed annually to ensure ongoing compliance with regulatory changes and emerging best practices.   BrightPath Neuro’s Infection Prevention and Control (IPC) Policy Alignment with CQC Key Lines of Enquiry (KLOEs) BrightPath Neuro’s Infection Prevention and Control (IPC) Policy aligns with the Care Quality Commission (CQC) Key Lines of Enquiry (KLOEs) by ensuring that infection prevention and control measures are embedded into clinical governance, operational processes, and service delivery. The policy reflects BrightPath Neuro’s commitment to safeguarding the health and well-being of service users, staff, and stakeholders through evidence-based infection control practices that comply with national and international standards, including ISO 9001 and NHS/NICE guidelines. Below is a detailed analysis of how the policy aligns with each CQC KLOE:  

1. Safe (S) The policy meets the requirements for ensuring that infection prevention and control practices protect individuals from harm and minimise health risks:

S1 – How do systems, processes, and practices keep people safe and safeguarded from abuse? The policy includes clear protocols for preventing, managing, and responding to infection control incidents. Risk assessments are conducted to identify vulnerabilities and ensure that measures are in place to reduce the risk of infection. Staff are required to adhere to strict hygiene protocols, including the use of Personal Protective Equipment (PPE). Protocols for handling hazardous materials, contaminated waste, and infection outbreaks are defined and monitored.

S2 – How are risks to people assessed, and how are they monitored and managed so they are supported to stay safe? The policy includes a structured process for risk assessment, identification, and mitigation related to infection control. Risks are assessed based on severity and likelihood using a structured framework aligned with ISO 9001. Staff are trained to identify infection risks and take corrective action to prevent escalation. Risk management includes monitoring for infection patterns and developing targeted action plans to prevent recurrence.

S3 – How does the service ensure the proper and safe use of medicines? While medication management is not directly related to infection control, the policy ensures that all medical equipment and pharmaceutical items are stored, handled, and disposed of in line with infection control guidelines. Signature RX handles the secure storage and disposal of medications in line with legal requirements.

S4 – How does the provider ensure the premises and equipment are safe and that people are protected from avoidable harm? Cleaning and disinfection protocols meet NHS and NICE standards. High-touch areas are cleaned and disinfected regularly to prevent the spread of infections. Equipment is sterilised according to NICE guidelines and monitored for compliance through regular audits. Environmental controls, including adequate ventilation and waste disposal, are managed in line with NHS environmental guidelines.

S5 – What is the track record on safety? Incident reports related to infection control are logged and reviewed by the IPC Lead. Performance data, including infection rates and compliance with cleaning protocols, is monitored monthly. Findings from audits and incident reviews are used to adjust protocols and improve staff training.  

2. Effective (E) The policy meets the requirements for ensuring that infection prevention and control practices are effective and based on current evidence and guidelines:

E1 – Are people’s needs and choices assessed, and is care, treatment, and support delivered in line with current legislation, standards, and evidence-based guidance? The policy aligns with the latest NICE, NHS, and World Health Organisation (WHO) guidelines on infection prevention and control. Staff follow the "5 Moments for Hand Hygiene" framework established by WHO. Personalised risk assessments are conducted to identify vulnerabilities and adjust infection control practices accordingly.

E2 – How does the service ensure that staff have the skills, knowledge, and experience to deliver effective care, support, and treatment? Staff receive regular infection control training that includes practical scenario-based learning. Competence in infection control practices is assessed annually as part of ISO 9001 performance reviews. Additional targeted training is provided for staff working in high-risk environments. Staff are updated regularly on changes to infection control protocols based on national and local guidelines.

E3 – How are staff, teams, and services working together to deliver effective care and support? Infection control measures are integrated into multi-disciplinary team (MDT) working arrangements. Information sharing between teams ensures consistent application of infection control protocols. Staff are encouraged to report infection risks or breaches through a structured reporting process.

E4 – How are people supported to live healthier lives and access care, support, and treatment? Staff and service users are encouraged to participate in health promotion initiatives related to infection control. Vaccination programs are available to staff and service users to protect against infectious diseases. Adjustments to care plans are made for individuals who are immunocompromised or at higher risk of infection.

E5 – How are people’s outcomes improved and sustainability of care ensured? Compliance with infection control protocols is monitored through regular audits and feedback. Outcomes from incident reports and audits are used to develop targeted improvement plans. Performance data is reviewed quarterly to identify trends and improve infection control practices.  

3. Caring (C) The policy meets the requirements for ensuring that infection prevention and control practices are delivered with compassion and respect:

C1 – How does the service ensure that people are treated with kindness, respect, and compassion, and that they are given emotional support when needed? Staff are trained to provide reassurance to service users during infection control procedures. Individuals who require isolation due to infectious diseases are supported with regular communication and emotional care. Staff are trained to recognise the emotional impact of infection control measures (e.g., isolation).

C2 – How does the service support people to express their views and be actively involved in making decisions about their care and treatment as far as possible? Service users are consulted on infection control measures that affect their care. Feedback on infection control measures is sought through surveys and direct communication. Adjustments are made to care plans to reflect service user preferences.

C3 – How is people’s privacy and dignity respected? Isolation protocols are designed to maintain the privacy and dignity of service users. Staff are trained to provide infection control care with sensitivity and discretion. PPE and hygiene protocols are implemented in a way that respects personal dignity.  

4. Responsive (R) The policy meets the requirements for ensuring that infection prevention and control measures are flexible and responsive to changing risks:

R1 – How do people receive personalised care that is responsive to their needs? Infection control measures are adjusted to reflect the individual health needs of service users. Risk assessments and care plans are tailored to accommodate individual vulnerabilities.

R2 – How does the service listen to and respond to complaints and concerns? Complaints related to infection control practices are logged and reviewed. Findings from complaints are shared with the IPC Lead to adjust protocols and training.

R3 – How are people’s concerns and complaints listened and responded to, and used to improve the quality of care? Complaints and incident reports are reviewed during governance meetings. Action plans are created to address concerns and improve infection control measures.  

5. Well-Led (W) The policy meets the requirements for ensuring that infection prevention and control governance and leadership are strong and effective:

W1 – Is there a clear vision and credible strategy to deliver high-quality care and support? The infection control strategy reflects BrightPath Neuro’s commitment to ISO 9001 quality management standards. Leadership oversight ensures that infection control practices are consistently applied.

W2 – Is there a clear governance framework that ensures quality, performance, and risk are managed effectively? The infection control framework includes regular audits, reporting, and governance reviews. The IPC Lead is responsible for strategic oversight and implementation.

W3 – Are the leaders aware of the risks and challenges, and are they acting to address them? Risks related to infection control are reviewed monthly. Action plans are developed to address gaps identified in audits or incident reports.

W4 – How does the service continuously learn, improve, and innovate? Lessons from incidents and audits are used to adjust infection control practices. Performance data is reviewed to identify opportunities for improvement.

W5 – How does the service work in partnership with other agencies? Infection control measures are aligned with local health authority and NHS guidelines.    

19. Policy Governance Policy Led: Paul Davis Infection Lead: Melanie Kennett Date Created: 21 March 2025 Next Review Date: 21 March 2026  .

Introduction BrightPath Neuro is committed to ensuring the safe, effective, and appropriate management of medications for all service users. This policy outlines the framework for prescribing, dispensing, administering, and monitoring medications in line with legal, ethical, and professional standards.   Medication management at BrightPath Neuro is integral to promoting the health and well-being of service users by minimising risks and ensuring the delivery of high-quality care. Medications are not considered a first-line treatment at BrightPath Neuro; they are introduced only when non-pharmacological interventions have been explored and where medication is deemed clinically appropriate.   BrightPath Neuro works in partnership with Signature RX, which handles all medication storage and disposal. BrightPath Neuro does not store, administer, or dispose of medications directly but retains responsibility for prescribing, monitoring, and reviewing medication as part of the overall treatment plan.  

2. Purpose The purpose of this policy is to: Define responsibilities and processes for managing medications safely and effectively. Ensure compliance with legal and regulatory requirements for medication management. Promote best practices in the prescribing, administration, and monitoring of medications. Safeguard service users by minimising risks associated with medication errors or misuse. Provide guidance on the governance of medication administration records (MAR). Ensure staff involved in prescribing and monitoring medications are trained, competent, and supported.   By adhering to this policy, BrightPath Neuro ensures that medication management practices meet the highest standards of safety, effectiveness, and accountability.  

3. Scope This policy applies to: All employees, contractors, and volunteers involved in the prescribing or monitoring of medications at BrightPath Neuro. All medications prescribed by BrightPath Neuro as part of a treatment plan for the following conditions: ADHD (Attention Deficit Hyperactivity Disorder) ASC (Autism Spectrum Condition) Sleep Disorders Dyslexia Mood Disorders (e.g., depression, anxiety) Weight Management Exclusions BrightPath Neuro does not handle the storage, dispensing, or disposal of medications. These activities are carried out by Signature RX under a formal partnership agreement. Medications are not directly administered by BrightPath Neuro staff except where a service user’s care plan specifies direct support.   This policy covers: Prescribing and transcribing. Storage and security (handled by Signature RX). Administration and monitoring. Governance of medication administration records (MAR). Staff training and competency in medication management. Incident reporting and investigation.  

4. Legislative and Regulatory Framework This policy aligns with the following legislation and guidance:   Medicines Act 1968 Governs the regulation, manufacture, and supply of medicines in the UK. The Misuse of Drugs Act 1971 Regulates the use of controlled substances to prevent misuse. The Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 Regulation 12: Requires providers to ensure the proper and safe management of medicines. Regulation 17: Requires providers to assess, monitor, and improve the quality of care. National Institute for Health and Care Excellence (NICE) Guidelines Provides evidence-based recommendations for the prescribing, administration, and monitoring of medications. The Equality Act 2010 Ensures equitable access to medication and prevents discrimination in care. The Data Protection Act 2018 and General Data Protection Regulation (GDPR) Protects the confidentiality of medication-related information. The Controlled Drugs (Supervision of Management and Use) Regulations 2013 Requires robust governance for the handling of controlled drugs.  

5. Definitions   Medication Any substance prescribed or administered to prevent, treat, or manage health conditions, including prescription medicines, over-the-counter drugs, and controlled substances.   Prescriber A qualified healthcare professional authorised to prescribe medications, such as doctors, nurse practitioners, or pharmacists.   Administration The process of giving a medication to a service user, including oral, topical, injectable, and other routes.   Controlled Drugs Medications regulated under the Misuse of Drugs Act 1971 due to their potential for misuse or harm. Medication Administration Record (MAR) A record used to document the administration of medications to a service user, including dosage, time, and route.  

6. Principles of Medication Management BrightPath Neuro follows key principles to ensure the safe and effective management of medications:   1. Person-Centred Care Service users are involved in decisions about their medication and are provided with clear, accessible information. Service users have the right to refuse medication unless it is required under the Mental Health Act. 2. Safety Prescriptions are reviewed regularly to ensure appropriateness and safety. Medication administration follows the Five Rights: Right Person Right Medication Right Dose Right Time Right Route 3. Compliance Medication management practices comply with all relevant legislation, guidelines, and standards. Prescribing is undertaken only by qualified and authorised healthcare professionals. 4. Accountability Staff are accountable for following protocols and reporting medication-related incidents or concerns. 5. Confidentiality Medication records and related information are kept secure and shared only with authorised individuals.  

7. Responsibilities Medication Management Lead – Steven Davis Oversees the implementation of the medication management framework. Ensures compliance with statutory and regulatory requirements. Reviews and monitors prescribing patterns for safety and effectiveness. Leads medication audits and reviews to ensure quality and safety.   Policy Lead – Paul Davis Responsible for ensuring that medication management policies and procedures are regularly reviewed and updated. Ensures that staff are informed of changes to medication management protocols.   Prescribers Only qualified and authorised healthcare professionals may prescribe medications. Prescriptions must be accurate, complete, and follow NICE guidelines. Prescribers are responsible for discussing potential side effects and reviewing medication effectiveness.     Signature RX Handles the storage, dispensing, and disposal of medications. Ensures that controlled drugs are stored in line with the Misuse of Drugs (Safe Custody) Regulations 1973.  

8. Key Medication Management Practices 1. Prescribing Only authorised prescribers may prescribe medications. Prescriptions must include the correct dosage, route, frequency, and duration.   2. Storage and Security Signature RX is responsible for the secure storage of all medications. Controlled drugs are stored in compliance with legal requirements.   3. Administration Medication administration follows the Five Rights principles. Administration is documented accurately in the MAR.   4. Disposal Expired or unused medications are disposed of by Signature RX. Medications are disposed of using approved methods to prevent misuse.  

9. Reporting Medication Incidents If a medication error or incident occurs, staff must: Identify the Issue – Document the error or concern. Inform the Medication Management Lead – Notify Steven Davis. Take Corrective Action – Implement measures to minimise harm. Document the Incident – Record the details in the error log. Review and Learn – Investigate the root cause of the incident.  

10. Governance and Monitoring Regular audits to monitor prescribing practices. Monthly reviews of MAR documentation for accuracy and completeness. Staff competency is reviewed annually.  

11. Monitoring and Review This policy will be reviewed annually or following significant incidents, legislative updates, or organisational changes.  

12. Compliance with ISO 9001 and Best Practices BrightPath Neuro’s Medication Management Policy is aligned with ISO 9001 Quality Management Standards and reflects best practices set out by the National Institute for Health and Care Excellence (NICE) and the NHS. The integration of ISO 9001 ensures that medication management processes are systematic, consistent, and continuously improved to maintain high standards of safety and clinical effectiveness.  

13.1 ISO 9001 Integration in Medication Management BrightPath Neuro’s compliance with ISO 9001 ensures that medication management is embedded into the overall governance and quality framework. The key elements of ISO 9001 applied to medication management include: Documented Processes: All prescribing, monitoring, and administration practices are clearly defined and documented. Risk-Based Approach: Medication-related risks are identified, assessed, and managed using a structured risk framework. Performance Monitoring: Prescribing, monitoring, and incident reporting practices are tracked through key performance indicators (KPIs). Audit and Review: Regular medication audits are conducted to assess compliance and identify areas for improvement. Corrective Actions: Findings from audits and incident reports are used to develop action plans and improve medication practices. As part of the ISO 9001 framework, BrightPath Neuro conducts an annual self-assessment of medication management practices. Findings from the assessment are used to adjust protocols, update training, and implement corrective actions where needed.  

13.2 NHS and NICE Best Practice Alignment BrightPath Neuro’s medication management practices align with the latest guidelines from the NHS and NICE to ensure evidence-based and person-centred care. Key areas of alignment include: Prescribing: Medications are prescribed in line with NICE guidelines for ADHD, ASC, mood disorders, and sleep disorders. Controlled drugs are prescribed in accordance with the Misuse of Drugs Act 1971 and NHS guidelines. Administration: Medication administration follows the NHS "Five Rights" principle: Right person Right medication Right dose Right time Right route Service users are involved in decisions about their medication, and informed consent is obtained where required. Monitoring and Review: Medication effectiveness and side effects are regularly monitored, and prescribing patterns are adjusted based on outcomes. NICE standards for medication monitoring (e.g., blood tests for ADHD medications) are followed. Incident Reporting: Medication errors are reported in line with NHS and local authority requirements. Root cause analysis is conducted to identify and address systemic issues.  

13.3 Controlled Drugs Management BrightPath Neuro’s management of controlled drugs is governed by the Controlled Drugs (Supervision of Management and Use) Regulations 2013 and follows NHS standards for safe prescribing and monitoring: Prescribing: Controlled drugs are only prescribed by qualified and authorised prescribers. Storage and Dispensing: Signature RX is responsible for the secure storage and dispensing of controlled drugs. Monitoring: Controlled drug prescriptions are reviewed regularly to prevent overuse or misuse. Audit: Controlled drug prescribing and monitoring are subject to quarterly audits.  

13.4 Staff Competence and Training All staff involved in prescribing, monitoring, or supporting medication administration receive training in medication management, aligned with ISO 9001 and NICE guidelines. This includes: Annual Competency Review: All prescribers and healthcare staff are required to demonstrate competence in medication management annually. Training in Controlled Drugs: Prescribers receive additional training on controlled drug management and legislation. Incident Management: Staff are trained in recognising, reporting, and responding to medication-related incidents. Person-Centred Care: Training includes involving service users in medication decisions and discussing potential side effects.  

13.5 Self-Assessment and Continuous Quality Improvement BrightPath Neuro conducts regular self-assessments and audits of medication management practices in line with ISO 9001 standards: Annual Self-Assessment: Medication management processes are reviewed annually to identify gaps and improvement opportunities. Quarterly Audits: Prescribing practices, MAR documentation, and incident reports are reviewed every three months. Performance Metrics: KPIs for medication safety, administration accuracy, and incident reporting are tracked and reported. Action Plans: Findings from audits and self-assessments are used to develop detailed action plans to address gaps and improve outcomes. Service User Feedback: Feedback from service users is gathered and used to adjust prescribing and monitoring practices.  

13.6 Risk Management and Incident Reporting BrightPath Neuro follows a structured approach to risk management and incident reporting, aligned with ISO 9001 and NHS standards: Identify: Staff are trained to identify potential medication risks, including incorrect prescriptions, missed doses, and side effects. Report: All medication incidents are reported immediately to the Medication Management Lead. Investigate: A root cause analysis is conducted for all medication-related incidents. Action: Findings from investigations are used to implement corrective actions and prevent recurrence. Review: Medication incidents are reviewed monthly to identify trends and emerging risks.  

13.7 Environmental Considerations BrightPath Neuro is committed to reducing environmental impact related to medication management: Safe Disposal: Signature RX ensures that medications, including controlled drugs, are disposed of using approved environmentally safe methods. Reducing Waste: Prescriptions are regularly reviewed to avoid overprescribing and minimise waste. Sustainable Practices: The use of paper-based MAR charts is reduced through the introduction of digital records where feasible.  

13.8 Performance Monitoring and Reporting BrightPath Neuro’s medication management performance is monitored through: Prescribing Audits: Conducted quarterly to assess compliance with prescribing standards and NICE guidelines. MAR Accuracy: Monthly reviews to ensure accurate and complete documentation of medication administration. Incident Data: Analysis of medication errors, near misses, and adverse drug reactions to identify trends and gaps. Service User Outcomes: Monitoring medication effectiveness and service user satisfaction. Staff Competency: Annual competency assessments to ensure staff knowledge and skills remain up to date.  

13.9 Governance and Oversight BrightPath Neuro’s medication management governance structure aligns with ISO 9001 standards: Role Responsibility Medication Management Lead – Steven Davis Oversees prescribing, monitoring, and reviewing of medications. Ensures compliance with regulatory and professional standards. Policy Lead – Paul Davis Ensures that medication management policies are updated and reflect current best practice. Signature RX Manages the storage, dispensing, and disposal of medications, including controlled drugs. Prescribers Ensure medications are prescribed appropriately and in line with NICE guidelines. Monitor medication effectiveness and safety. Clinical Team Ensure accurate administration of medications and timely reporting of any issues.  

14. Performance and Continuous Improvement BrightPath Neuro is committed to improving medication management practices through: Benchmarking: Comparing prescribing and administration performance with national NHS data. Service User Engagement: Involving service users in medication decisions and gathering feedback on medication effectiveness. Training and Development: Updating staff training regularly to reflect changes in guidelines and emerging evidence. Annual Quality Improvement Plan: Findings from audits and self-assessments are used to develop a structured plan for improving medication safety and effectiveness.  

15. Conclusion This Medication Management Policy reflects BrightPath Neuro’s commitment to delivering high-quality, safe, and effective medication practices. By aligning with ISO 9001 standards, NICE guidelines, and NHS best practice, BrightPath Neuro ensures that medication management is evidence-based, person-centred, and continuously improved.  

BrightPath Neuro’s Medication Management Policy Alignment with CQC Key Lines of Enquiry (KLOEs) BrightPath Neuro’s Medication Management Policy aligns with the Care Quality Commission (CQC) Key Lines of Enquiry (KLOEs) by ensuring that medication management practices are safe, effective, person-centred, and compliant with national standards. The policy reflects BrightPath Neuro’s commitment to providing high-quality care through robust governance, accountability, and continuous improvement. Below is a detailed analysis of how the policy aligns with each CQC KLOE:  

1. Safe (S) The policy meets the requirements for ensuring that medication management processes protect individuals from harm and promote safe care practices.

S1 – How do systems, processes, and practices keep people safe and safeguarded from abuse? All medications are prescribed, monitored, and reviewed by qualified and authorised healthcare professionals. Medications are prescribed in line with NICE guidelines and NHS best practices. A robust governance framework ensures that medication-related incidents are reported, investigated, and resolved promptly. Risk assessments are conducted to identify vulnerabilities and ensure appropriate medication management strategies.  

S2 – How are risks to people assessed, and how are they monitored and managed so they are supported to stay safe? A structured risk management process is in place to identify and assess medication-related risks. Regular medication reviews are conducted to monitor side effects, interactions, and effectiveness. Incident reporting and root cause analysis are used to address medication errors and prevent recurrence. Service users’ medical history and potential contraindications are considered before prescribing.  

S3 – How does the service ensure the proper and safe use of medicines? Medication prescribing, administration, and monitoring follow the NHS "Five Rights" principle: Right Person Right Medication Right Dose Right Time Right Route Signature RX is responsible for the secure storage and disposal of medications, ensuring that controlled drugs are stored in line with the Misuse of Drugs Act 1971. Controlled drugs are managed under the Controlled Drugs (Supervision of Management and Use) Regulations 2013 with regular audits and oversight. All medication administration is accurately recorded in the Medication Administration Record (MAR).  

S4 – How does the provider ensure the premises and equipment are safe and that people are protected from avoidable harm? Signature RX ensures that medications are stored securely and in compliance with legal requirements. Expired or unused medications are disposed of using approved methods to prevent misuse. Clinical environments are regularly audited to ensure compliance with medication handling and administration guidelines.  

S5 – What is the track record on safety? Regular audits and MAR reviews are conducted to track medication safety and effectiveness. Performance data on medication errors, side effects, and prescribing patterns are reviewed monthly. Corrective actions are implemented where gaps are identified, and lessons are shared with staff to improve practice.  

2. Effective (E) The policy meets the requirements for ensuring that medication management practices are effective, evidence-based, and aligned with national guidelines.

E1 – Are people’s needs and choices assessed, and is care, treatment, and support delivered in line with current legislation, standards, and evidence-based guidance? Medication management follows NICE guidelines and NHS standards. Decisions about medication are person-centred and based on a comprehensive clinical assessment. Non-pharmacological interventions are explored before medications are introduced. Regular medication reviews are conducted to evaluate effectiveness and side effects.  

E2 – How does the service ensure that staff have the skills, knowledge, and experience to deliver effective care, support, and treatment? Staff involved in prescribing and medication monitoring are trained and competent. Annual competency assessments ensure that prescribers and healthcare staff meet professional standards. Additional training on controlled drug prescribing and monitoring is provided to staff working with high-risk medications.  

E3 – How are staff, teams, and services working together to deliver effective care and support? Multi-disciplinary team (MDT) working is integrated into the medication management process. Communication between prescribers, pharmacists, and support staff ensures coordinated care. Regular case reviews and handovers are conducted to assess medication effectiveness and adjust treatment plans accordingly.

E4 – How are people supported to live healthier lives and access care, support, and treatment? Service users are actively involved in medication decisions and provided with accessible information about side effects and alternatives. Weight management and mental health support are integrated into care plans. Medication use is aligned with broader health and lifestyle goals, including improved sleep and emotional regulation.  

E5 – How are people’s outcomes improved and sustainability of care ensured? Clinical outcomes are monitored using performance data and service user feedback. Adjustments to medication and care plans are made based on clinical reviews and outcome data. Lessons from medication incidents are incorporated into future prescribing practices.  

3. Caring (C) The policy meets the requirements for ensuring that medication management practices are delivered with respect and compassion.

C1 – How does the service ensure that people are treated with kindness, respect, and compassion, and that they are given emotional support when needed? Prescribers discuss potential side effects and benefits with service users to support informed decision-making. Staff are trained to provide emotional support when discussing medication options. Service users' preferences and concerns about medication are respected.  

C2 – How does the service support people to express their views and be actively involved in making decisions about their care and treatment as far as possible? Service users are encouraged to express their preferences regarding medication. Alternative treatments and adjustments to medication plans are discussed with service users. Informed consent is obtained before initiating or changing medication. C3 – How is people’s privacy and dignity respected? Medication administration is conducted in a private and respectful manner. Service users' medication records are handled in line with GDPR requirements. Staff are trained to provide support in a non-judgmental and respectful way.  

4. Responsive (R) The policy meets the requirements for ensuring that medication management practices are responsive to service users' needs and preferences.

R1 – How do people receive personalised care that is responsive to their needs? Medication plans are tailored to individual needs and adjusted based on service user feedback. Medication effectiveness and side effects are monitored, with changes made as needed. Person-centred care is integrated into medication reviews and decisions.  

R2 – How are people’s concerns and complaints listened to and responded to, and how are improvements made? Service users are encouraged to report medication concerns or side effects. Complaints and medication errors are reviewed, and corrective actions are implemented. Lessons learned from complaints are used to improve prescribing and monitoring practices.  

R3 – How are people supported to have access to the right care, treatment, and support at the right time? Flexible appointment options are available to accommodate service users' needs. Emergency medication reviews are available for urgent issues or side effects. Prescriptions are managed to avoid gaps or delays in medication availability.  

5. Well-Led (W) The policy meets the requirements for ensuring that medication management practices are supported by strong leadership and governance.

W1 – Is there a clear vision and credible strategy to deliver high-quality care and support, and promote a positive culture? Medication management is integrated into BrightPath Neuro’s overall governance and quality framework. A Medication Management Lead oversees compliance and improvement initiatives. Policies and procedures are regularly reviewed to reflect current legislation and best practices.  

W2 – Are there clear responsibilities, roles, systems of accountability, and governance arrangements to support good care and management? The Medication Management Lead is accountable for prescribing and monitoring practices. Signature RX is responsible for secure storage and disposal of medications. Staff are accountable for adhering to prescribing and administration guidelines.  

W3 – How does the service engage and involve people in the development of its services? Service user feedback is actively sought and used to improve medication practices. Feedback from staff and families is used to inform policy changes and improvements.  

W4 – How does the service continuously learn, improve, innovate, and ensure sustainability? Medication management practices are reviewed through regular audits and KPI monitoring. Findings from audits and incident reports are used to improve prescribing and administration practices. Performance data is shared with staff to promote a culture of learning and improvement.    

16. Policy Governance Policy Lead: Paul Davis Medication Management Lead: Steven Davis Date Created: 21 March 2025 Next Review Date: 21 March 2026

Introduction BrightPath Neuro is committed to ensuring that all recruitment processes are fair, transparent, and compliant with legal and ethical standards. Our recruitment practices are designed to attract and select the best candidates while promoting equality, diversity, and inclusion.   BrightPath Neuro recognises that effective recruitment is essential to delivering high-quality services and maintaining a workforce that reflects the diverse needs of our service users. This policy sets out the framework for recruiting and appointing staff, apprentices, and volunteers in a consistent, fair, and lawful manner.  

BrightPath Neuro is committed to safeguarding service users and ensuring that all staff employed are suitable to work with children, vulnerable adults, and individuals with complex needs.  

2. Purpose The purpose of this policy is to: Ensure that recruitment processes are fair, transparent, and based on merit. Ensure compliance with relevant employment legislation and safeguarding requirements. Promote diversity and inclusion within the workforce. Safeguard the well-being of service users by ensuring that all staff are suitable to work with vulnerable individuals. Ensure that recruitment processes are consistent and applied equally across all departments.  

3. Scope This policy applies to: All permanent, temporary, and fixed-term staff employed by BrightPath Neuro. All volunteers, contractors, and apprentices. All individuals involved in the recruitment, selection, and onboarding of new staff.   This policy covers all stages of recruitment, including: Advertising roles Application and shortlisting Interview and selection Pre-employment checks (including references and DBS checks) Offer of employment and induction  

4. Legal Framework This policy complies with the following legislation and guidance:   The Equality Act 2010 Prohibits discrimination in recruitment and selection on the grounds of protected characteristics, including: Age Disability Gender reassignment Marriage and civil partnership Pregnancy and maternity Race Religion or belief Sex Sexual orientation   The Employment Rights Act 1996 Protects employees from unfair treatment and dismissal.   The Data Protection Act 2018 and General Data Protection Regulation (GDPR) Requires that candidate information is processed and stored securely. Ensures that candidate information is not shared without consent.   Rehabilitation of Offenders Act 1974 Allows employers to ask about spent and unspent convictions for roles involving children and vulnerable adults.   The Safeguarding Vulnerable Groups Act 2006 Sets out legal requirements for DBS checks and employment suitability.  

5. Principles of Recruitment BrightPath Neuro follows the following principles to ensure fair, transparent, and effective recruitment:

1. Fair and Equal Opportunity All candidates are treated with dignity and respect throughout the recruitment process. All recruitment decisions are based on merit and the candidate’s ability to meet the job requirements. Reasonable adjustments are made to the recruitment process to accommodate candidates with disabilities.  

2. Transparency All job descriptions, person specifications, and selection criteria are clearly communicated. Candidates are provided with clear information about the selection process and expected timelines.  

3. Safeguarding All roles involving children, vulnerable adults, or individuals with complex needs require a Disclosure and Barring Service (DBS) check. Candidates must disclose any previous convictions or disciplinary action that may affect their suitability for the role.  

4. Confidentiality All candidate information is treated confidentially and in accordance with GDPR requirements. Access to candidate information is restricted to those involved in the recruitment process.      

6. Recruitment Process

1. Job Advert All job vacancies are advertised through appropriate channels to ensure equal access. Job adverts include: Job title Key responsibilities and person specification Qualifications and experience required Salary and benefits Closing date for applications Adverts are designed to avoid discriminatory language or criteria.  

2. Application and Shortlisting Applications are submitted using a standardised application form. The recruitment panel is responsible for shortlisting candidates against the essential and desirable criteria outlined in the job description and person specification. Candidates are notified promptly if they are unsuccessful at the shortlisting stage.  

3. Interview and Selection Interviews are conducted by a panel that includes the Recruitment Lead or their delegate. All interview questions are structured and based on the person specification and job requirements. Candidates are asked to demonstrate how they meet the selection criteria using examples from their experience. Reasonable adjustments are made for candidates with disabilities. Notes from the interview are recorded and retained in line with data protection requirements.  

4. Pre-Employment Checks All offers of employment are subject to the following checks:   Identity Checks – Passport, driving licence, or other legal identification. DBS Check – All roles involving children or vulnerable adults require an enhanced DBS check. Right to Work Check – Verification that the candidate is legally entitled to work in the UK. Professional Qualifications – Verification of qualifications where relevant to the role. References – Two references are required, including: One reference from the candidate’s most recent employer. For roles involving children or vulnerable adults, references must confirm suitability and reasons for leaving previous employment.  

5. Offer of Employment The successful candidate is provided with a written offer of employment, including: Job title Start date Salary and benefits Contract terms Conditions of employment (including DBS and reference checks) Candidates must sign and return the contract of employment before their start date.

6. Induction and Training All new staff receive a structured induction, which includes: Company policies and procedures Safeguarding training Health and safety protocols Role-specific training Ongoing competency assessments  

7. Recruitment of Volunteers and Apprentices Volunteers and apprentices undergo the same recruitment checks as paid employees. Volunteers receive a full induction and safeguarding training. DBS checks are required for volunteers and apprentices involved in roles with children or vulnerable adults.

8. Monitoring and Complaints

1. Monitoring Recruitment processes are monitored to ensure compliance with legal requirements and best practices. Recruitment data (e.g., diversity monitoring) is analysed regularly to identify and address any inequalities or biases.  

2. Complaints Candidates who feel they have been treated unfairly or discriminated against may file a formal complaint with the Recruitment Lead. Complaints are investigated promptly, and outcomes are communicated to the complainant within 10 working days. Complaints are reviewed to identify areas for improvement in recruitment practices.  

9. Data Protection and Confidentiality All personal data collected during the recruitment process is handled in accordance with the Data Protection Act 2018 and GDPR. Personal data is retained only as long as necessary and securely destroyed when no longer needed.  

10. Governance and Accountability Recruitment Lead – Steven Davis Oversees all recruitment activities. Ensures recruitment practices align with legal and regulatory requirements. Reviews and updates recruitment processes to maintain compliance and fairness.   Policy Led – Paul Davis Ensures that the recruitment policy is up to date and reflects best practices. Monitors recruitment data to identify trends and potential improvements.   .

13. Compliance with ISO 9001 and Best Practice in Recruitment BrightPath Neuro’s Recruitment Policy is aligned with ISO 9001 Quality Management Standards and reflects best practices established by the NHS and CQC for fair and effective recruitment. The integration of ISO 9001 into recruitment processes ensures that recruitment activities are transparent, consistent, and continuously improved to maintain the highest standards of employment practice and organisational integrity.   1

3.1 ISO 9001 Integration in Recruitment Practices BrightPath Neuro’s compliance with ISO 9001 ensures that recruitment processes are systematically designed, monitored, and evaluated. The key elements of ISO 9001 applied to recruitment include: Documented Recruitment Processes: All stages of the recruitment process, including advertising, shortlisting, interviews, and offers, are clearly defined and documented. Risk-Based Approach: Risks associated with recruitment, such as unsuitable candidates or bias, are identified and mitigated through structured procedures. Performance Monitoring: Recruitment KPIs (e.g., time to hire, diversity of candidates, and retention rates) are tracked and reported quarterly. Continuous Improvement: Findings from recruitment audits and feedback are used to improve recruitment processes and reduce inefficiencies. Audit and Review: Recruitment processes are subject to regular internal and external audits to maintain compliance with ISO 9001 standards.  

13.2 NHS and CQC Best Practice Alignment BrightPath Neuro’s recruitment practices align with NHS and CQC guidelines to ensure that recruitment is ethical, transparent, and person-centred. Key areas of alignment include: Fair and Transparent Process: Job descriptions, person specifications, and interview criteria are clearly communicated and accessible. All recruitment decisions are based on the applicant’s ability to meet the requirements of the role. Safeguarding: Enhanced DBS checks are mandatory for roles involving vulnerable adults or children, in line with NHS employment guidelines. Risk assessments are conducted for any safeguarding concerns identified during recruitment. Equal Opportunity: Reasonable adjustments are made for candidates with disabilities. All recruitment decisions are in line with the Equality Act 2010 to prevent discrimination and bias. Professional Standards: Verification of professional qualifications, registration (e.g., NMC, HCPC), and employment history is conducted in line with NHS employment standards.  

13.3 Data Protection and Confidentiality BrightPath Neuro’s recruitment data management practices comply with GDPR and ISO 9001 requirements to ensure that candidate information is handled securely and confidentially: Data Storage: Candidate information is stored securely in line with data retention policies. Only authorised staff have access to recruitment data. Retention and Disposal: Recruitment data is retained only for the period specified in the Data Retention Policy. Data is securely deleted or destroyed when no longer required. Consent: Candidates are informed about how their data will be processed. Explicit consent is obtained for storing and processing sensitive personal data.  

13.4 Self-Assessment and Continuous Quality Improvement BrightPath Neuro conducts annual self-assessments of recruitment practices as part of ISO 9001 compliance to evaluate performance and identify areas for improvement: Quarterly Recruitment Audits: Recruitment data (e.g., diversity monitoring, hiring time, turnover) is reviewed to assess performance and fairness. Candidate Feedback: Feedback from candidates is collected after each recruitment round to identify strengths and areas for improvement. Findings are incorporated into the recruitment strategy. Performance Metrics: Key performance indicators (KPIs) are tracked, including: Time to hire Percentage of diverse hires Candidate satisfaction rates Retention rates Corrective Actions: Findings from self-assessments are used to adjust recruitment strategies and address gaps in candidate experience or selection bias.  

13.5 Diversity and Inclusion in Recruitment BrightPath Neuro actively promotes diversity and inclusion within the recruitment process, ensuring compliance with ISO 9001 and the Equality Act 2010: Outreach and Accessibility: Jobs are advertised through diverse channels to reach underrepresented groups. Recruitment materials are available in multiple languages and alternative formats. Reasonable Adjustments: Adjustments are made to accommodate candidates with disabilities during interviews and assessments. This includes providing accessible venues, modified interview formats, and additional time. Bias-Free Recruitment Panels: Recruitment panels include trained staff to ensure impartiality and prevent unconscious bias. Structured scoring systems are used to assess candidates based on objective criteria.  

13.6 Risk Management in Recruitment BrightPath Neuro’s recruitment process includes a structured approach to managing risks: Recruitment Risk Register: Risks associated with recruitment, such as candidate fraud, safeguarding issues, and retention challenges, are recorded and monitored. Pre-Employment Checks: Enhanced DBS checks and professional reference verifications are mandatory for all roles involving vulnerable individuals. If a safeguarding concern arises, the appointment is suspended until the issue is resolved. Contingency Planning: Recruitment gaps are mitigated through temporary staffing arrangements and internal redeployment. Critical roles are identified, and succession plans are developed.  

13.7 Recruitment Monitoring and Reporting BrightPath Neuro’s recruitment performance is tracked through: Recruitment Dashboard: A central dashboard is used to track performance against recruitment KPIs. Trends in hiring times, candidate quality, and turnover rates are analysed monthly. Quarterly Reports: Reports are submitted to the senior leadership team to evaluate recruitment outcomes and identify areas for improvement. Equal Opportunity and Diversity Monitoring: Diversity data is reviewed to ensure that recruitment practices reflect the diversity of the local community. Adjustments are made to address any underrepresentation.  

13.8 Staff Competence and Training All staff involved in recruitment receive training in best practices and ISO 9001 compliance: Recruitment Training: Annual training on conducting fair, transparent, and bias-free recruitment. Scenario-based learning on unconscious bias and reasonable adjustments. Safeguarding Training: Staff involved in recruitment for roles with vulnerable individuals receive additional training on safeguarding requirements and risk assessments. Data Protection Training: Training on GDPR compliance and secure handling of candidate information.  

13.9 Governance and Oversight BrightPath Neuro’s recruitment governance structure aligns with ISO 9001 requirements for accountability and oversight: Role Responsibility Recruitment Lead – Steven Davis Oversees recruitment processes, ensures compliance with employment law, and manages recruitment performance. Policy Lead – Paul Davis Ensures that recruitment policies reflect legal and best practice changes; monitors recruitment data to assess effectiveness. Recruitment Panel Responsible for fair and consistent candidate assessment; ensures decisions align with job requirements. Safeguarding Lead Ensures that all safeguarding checks are conducted and any concerns are managed appropriately.  

14. Performance and Continuous Improvement BrightPath Neuro is committed to continuous improvement in recruitment practices through: Benchmarking: Comparing recruitment performance with national and regional data to identify trends and gaps. Staff and Candidate Feedback: Feedback from staff and candidates is analysed and used to improve recruitment processes. Annual Quality Improvement Plan: Findings from audits, feedback, and self-assessments are incorporated into an annual plan for improving recruitment practices. Diversity and Inclusion Strategy: Targets for increasing representation of minority and underrepresented groups are incorporated into recruitment strategies.   15. Conclusion This Recruitment Policy reflects BrightPath Neuro’s commitment to delivering fair, transparent, and effective recruitment practices.

By aligning with ISO 9001, NHS employment guidelines, and the Equality Act 2010, BrightPath Neuro ensures that recruitment decisions are evidence-based, bias-free, and consistent with national standards.   BrightPath Neuro’s Medication Management Policy Alignment with CQC Key Lines of Enquiry (KLOEs) BrightPath Neuro’s Medication Management Policy aligns with the Care Quality Commission (CQC) Key Lines of Enquiry (KLOEs) by ensuring that medication management practices are safe, effective, person-centred, and compliant with national standards.

The policy reflects BrightPath Neuro’s commitment to providing high-quality care through robust governance, accountability, and continuous improvement. Below is a detailed analysis of how the policy aligns with each CQC KLOE:  

1. Safe (S) The policy meets the requirements for ensuring that medication management processes protect individuals from harm and promote safe care practices. S1 – How do systems, processes, and practices keep people safe and safeguarded from abuse? All medications are prescribed, monitored, and reviewed by qualified and authorised healthcare professionals. Medications are prescribed in line with NICE guidelines and NHS best practices. A robust governance framework ensures that medication-related incidents are reported, investigated, and resolved promptly. Risk assessments are conducted to identify vulnerabilities and ensure appropriate medication management strategies.  

S2 – How are risks to people assessed, and how are they monitored and managed so they are supported to stay safe? A structured risk management process is in place to identify and assess medication-related risks. Regular medication reviews are conducted to monitor side effects, interactions, and effectiveness. Incident reporting and root cause analysis are used to address medication errors and prevent recurrence. Service users’ medical history and potential contraindications are considered before prescribing.  

S3 – How does the service ensure the proper and safe use of medicines? Medication prescribing, administration, and monitoring follow the NHS "Five Rights" principle: Right Person Right Medication Right Dose Right Time Right Route Signature RX is responsible for the secure storage and disposal of medications, ensuring that controlled drugs are stored in line with the Misuse of Drugs Act 1971. Controlled drugs are managed under the Controlled Drugs (Supervision of Management and Use) Regulations 2013 with regular audits and oversight. All medication administration is accurately recorded in the Medication Administration Record (MAR).  

S4 – How does the provider ensure the premises and equipment are safe and that people are protected from avoidable harm? Signature RX ensures that medications are stored securely and in compliance with legal requirements. Expired or unused medications are disposed of using approved methods to prevent misuse. Clinical environments are regularly audited to ensure compliance with medication handling and administration guidelines.  

S5 – What is the track record on safety? Regular audits and MAR reviews are conducted to track medication safety and effectiveness. Performance data on medication errors, side effects, and prescribing patterns are reviewed monthly. Corrective actions are implemented where gaps are identified, and lessons are shared with staff to improve practice.  

2. Effective (E) The policy meets the requirements for ensuring that medication management practices are effective, evidence-based, and aligned with national guidelines.

E1 – Are people’s needs and choices assessed, and is care, treatment, and support delivered in line with current legislation, standards, and evidence-based guidance? Medication management follows NICE guidelines and NHS standards. Decisions about medication are person-centred and based on a comprehensive clinical assessment. Non-pharmacological interventions are explored before medications are introduced. Regular medication reviews are conducted to evaluate effectiveness and side effects.  

E2 – How does the service ensure that staff have the skills, knowledge, and experience to deliver effective care, support, and treatment? Staff involved in prescribing and medication monitoring are trained and competent. Annual competency assessments ensure that prescribers and healthcare staff meet professional standards. Additional training on controlled drug prescribing and monitoring is provided to staff working with high-risk medications.  

E3 – How are staff, teams, and services working together to deliver effective care and support? Multi-disciplinary team (MDT) working is integrated into the medication management process. Communication between prescribers, pharmacists, and support staff ensures coordinated care. Regular case reviews and handovers are conducted to assess medication effectiveness and adjust treatment plans accordingly.  

E4 – How are people supported to live healthier lives and access care, support, and treatment? Service users are actively involved in medication decisions and provided with accessible information about side effects and alternatives. Weight management and mental health support are integrated into care plans. Medication use is aligned with broader health and lifestyle goals, including improved sleep and emotional regulation.  

E5 – How are people’s outcomes improved and sustainability of care ensured? Clinical outcomes are monitored using performance data and service user feedback. Adjustments to medication and care plans are made based on clinical reviews and outcome data. Lessons from medication incidents are incorporated into future prescribing practices.  

3. Caring (C) The policy meets the requirements for ensuring that medication management practices are delivered with respect and compassion.

C1 – How does the service ensure that people are treated with kindness, respect, and compassion, and that they are given emotional support when needed? Prescribers discuss potential side effects and benefits with service users to support informed decision-making. Staff are trained to provide emotional support when discussing medication options. Service users' preferences and concerns about medication are respected.  

C2 – How does the service support people to express their views and be actively involved in making decisions about their care and treatment as far as possible? Service users are encouraged to express their preferences regarding medication. Alternative treatments and adjustments to medication plans are discussed with service users. Informed consent is obtained before initiating or changing medication. C3 – How is people’s privacy and dignity respected? Medication administration is conducted in a private and respectful manner. Service users' medication records are handled in line with GDPR requirements. Staff are trained to provide support in a non-judgmental and respectful way.  

4. Responsive (R) The policy meets the requirements for ensuring that medication management practices are responsive to service users' needs and preferences.

R1 – How do people receive personalised care that is responsive to their needs? Medication plans are tailored to individual needs and adjusted based on service user feedback. Medication effectiveness and side effects are monitored, with changes made as needed. Person-centred care is integrated into medication reviews and decisions.  

R2 – How are people’s concerns and complaints listened to and responded to, and how are improvements made? Service users are encouraged to report medication concerns or side effects. Complaints and medication errors are reviewed, and corrective actions are implemented. Lessons learned from complaints are used to improve prescribing and monitoring practices.  

R3 – How are people supported to have access to the right care, treatment, and support at the right time? Flexible appointment options are available to accommodate service users' needs. Emergency medication reviews are available for urgent issues or side effects. Prescriptions are managed to avoid gaps or delays in medication availability.  

5. Well-Led (W) The policy meets the requirements for ensuring that medication management practices are supported by strong leadership and governance.

W1 – Is there a clear vision and credible strategy to deliver high-quality care and support, and promote a positive culture? Medication management is integrated into BrightPath Neuro’s overall governance and quality framework. A Medication Management Lead oversees compliance and improvement initiatives. Policies and procedures are regularly reviewed to reflect current legislation and best practices.  

W2 – Are there clear responsibilities, roles, systems of accountability, and governance arrangements to support good care and management? The Medication Management Lead is accountable for prescribing and monitoring practices. Signature RX is responsible for secure storage and disposal of medications. Staff are accountable for adhering to prescribing and administration guidelines.  

W3 – How does the service engage and involve people in the development of its services? Service user feedback is actively sought and used to improve medication practices. Feedback from staff and families is used to inform policy changes and improvements.  

W4 – How does the service continuously learn, improve, innovate, and ensure sustainability? Medication management practices are reviewed through regular audits and KPI monitoring. Findings from audits and incident reports are used to improve prescribing and administration practices. Performance data is shared with staff to promote a culture of learning and improvement. Bottom of Form    

16. Policy Governance

Policy Led: Paul Davis

Recruitment Lead: Steven Davis Date

Created: 21 March 2025

Next Review Date: 21 March 2026  

If you have a safeguarding concern, please contact us immediately. Our team takes safeguarding very seriously and follows strict protocols to ensure the safety and well-being of all clients. You can also report your concern directly by filling out our safeguarding form and reading our full Safeguarding Policy here.

 👉 Submit a Safeguarding concern,

Brightpath Neuro Safeguarding Policy

1. Introduction Brightpath Neuro is committed to safeguarding and promoting the welfare of children, young people, and vulnerable adults. We have a duty of care to protect individuals from abuse, neglect, and exploitation. This policy outlines our approach to safeguarding, including the roles and responsibilities of staff and the procedures to follow in the event of a safeguarding concern.

2. Purpose The purpose of this policy is to: Ensure a safe and secure environment for all service users. Promote the well-being of children, young people, and vulnerable adults. Ensure that staff understand their safeguarding responsibilities. Provide clear procedures for reporting and responding to safeguarding concerns.

3. Scope This policy applies to: All staff, contractors, and volunteers working for Brightpath Neuro. All individuals receiving services from Brightpath Neuro, including children, young people, and vulnerable adults. Any external partners or agencies working with Brightpath Neuro.

4. Legal Framework This policy is based on the following legislation and guidance: Children Act 1989 and 2004 Care Act 2014 Working Together to Safeguard Children (2018) Keeping Children Safe in Education (2023) Protection of Freedoms Act 2012 Data Protection Act 2018 and UK GDPR Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 Safeguarding Vulnerable Groups Act 2006

5. Definitions 5.1 Safeguarding Safeguarding refers to the actions taken to protect the health, well-being, and human rights of individuals, particularly children and vulnerable adults, to prevent abuse, neglect, and exploitation. 5.2 Vulnerable Adult A person aged 18 or over who: Has care and support needs. Is unable to protect themselves from harm or exploitation due to their care and support needs. 5.3 Abuse Abuse is any action or inaction that causes harm, distress, or exploitation. Types of abuse include: Physical abuse – Assault, hitting, slapping, pushing, or misuse of medication. Sexual abuse – Non-consensual sexual activity or inappropriate touching. Emotional abuse – Verbal attacks, humiliation, or threats. Neglect – Failure to meet basic needs such as food, clothing, and healthcare. Financial abuse – Theft, fraud, or coercion in relation to money or property. Discriminatory abuse – Harassment or ill-treatment due to race, gender, age, or disability. Institutional abuse – Poor care practices within a service setting. Modern slavery – Forced labour, human trafficking, and exploitation.

6. Safeguarding Principles Brightpath Neuro follows the six key safeguarding principles established in the Care Act 2014: Empowerment – Supporting individuals to make their own decisions. Prevention – Taking action before harm occurs. Proportionality – Responding appropriately to the level of risk. Protection – Providing support to those in greatest need. Partnership – Working with other agencies to safeguard effectively. Accountability – Ensuring transparency and clear decision-making.

7. Roles and Responsibilities 7.1 Safeguarding Lead The Designated Safeguarding Lead (DSL) is responsible for: Overseeing safeguarding procedures. Acting as the primary contact for safeguarding concerns. Ensuring all staff receive safeguarding training. Liaising with external agencies, including social services and the police. 7.2 Staff and Volunteers All staff and volunteers have a responsibility to: Be aware of the signs of abuse and neglect. Report safeguarding concerns to the DSL immediately. Follow safeguarding procedures outlined in this policy. Maintain confidentiality and professionalism when handling safeguarding issues. 7.3 Management Senior management is responsible for: Ensuring that safeguarding policies and procedures are implemented. Providing resources for staff training and development. Monitoring safeguarding performance and compliance.

8. Safeguarding Procedures 8.1 Identifying a Safeguarding Concern All staff should be aware of the following signs that may indicate abuse or neglect: Unexplained injuries or bruising. Sudden changes in behaviour or mood. Poor hygiene or malnutrition. Fearfulness, withdrawal, or reluctance to speak. Financial discrepancies or missing belongings. 8.2 Reporting a Concern Any safeguarding concern must be reported immediately to the DSL. If the DSL is unavailable, the report should be escalated to senior management. Staff must record details of the concern accurately, including dates, times, and any actions taken. Reports should be made within 24 hours of the concern being identified. 8.3 Responding to a Concern The DSL will assess the severity of the concern and take appropriate action. This may include: Contacting social services. Involving the police if a crime has been committed. Offering immediate support to the affected individual. The individual’s consent will be sought before sharing information unless there is a significant risk of harm. 8.4 Confidentiality and Information Sharing Information will only be shared on a need-to-know basis. Safeguarding information will be stored securely in line with data protection laws. Staff must not disclose safeguarding information to unauthorised individuals. 8.5 Escalation Process If a safeguarding concern is not resolved satisfactorily, staff and clients can escalate the issue to: Local Safeguarding Adults Board Local Safeguarding Children Partnership Care Quality Commission (CQC) Local Authority Safeguarding Team

9. Training and Development All staff must receive safeguarding training at least once per year. New staff must complete safeguarding training as part of their induction. The DSL must complete enhanced safeguarding training and regular updates.

10. Safer Recruitment Brightpath Neuro is committed to recruiting staff safely: All staff undergo Enhanced DBS (Disclosure and Barring Service) checks. References are checked prior to employment. Staff are assessed for suitability to work with vulnerable groups.

11. Allegations Against Staff Any allegation against a staff member must be reported immediately to the DSL. The staff member may be suspended while an investigation takes place. Investigations will be carried out in line with local safeguarding procedures.

12. Whistleblowing Brightpath Neuro encourages staff to report any safeguarding concerns without fear of retaliation. Whistleblowers are protected under the Public Interest Disclosure Act 1998. Concerns should be reported directly to the DSL or senior management.

13. Monitoring and Review All safeguarding incidents and outcomes will be recorded and reviewed. This policy will be reviewed annually or after any major safeguarding incident. Feedback from staff and service users will be used to update this policy where appropriate.

Introduction At Brightpath Neuro, we strive to provide high-quality neurodiversity and mental health services. We understand that circumstances may arise where you need to cancel or request a refund for a service. This Refund Policy outlines the terms and conditions under which refunds are granted for services provided by Brightpath Neuro.

 👉 Submit a Refund Request

2. Scope This policy applies to all services offered by Brightpath Neuro, including but not limited to: ADHD, Autism (ASC), and Dyslexia Assessments Sleep Assessments Weight Management Services Mood and Mental Health Support

3. Eligibility for Refund Refunds are available under the following circumstances:

3.1 Cancellation by Brightpath Neuro If Brightpath Neuro cancels a service due to unforeseen circumstances or staff availability, you will be offered the option to: Reschedule the appointment at no additional cost, OR Receive a full refund within 7 business days of the cancellation.

3.2 Client Cancellation You may cancel a booking and be eligible for a refund under the following terms: Cancellation Period Refund Amount More than 48 hours before the appointment100% refund Within 24 to 48 hours before the appointment50% refund Less than 24 hours before the appointment or failure to attend No refund If you cancel due to a medical emergency or other extenuating circumstances, Brightpath Neuro may offer a full or partial refund at the discretion of the management team. Supporting documentation (e.g., medical certificate) may be requested. 3.3 Dissatisfaction with Service If you are dissatisfied with the service provided, you must notify Brightpath Neuro in writing within 5 working days of the appointment. A full or partial refund may be granted if: The service was not delivered as described. There was a significant error in the assessment or report. The service did not meet professional or contractual standards. Refund requests will be reviewed by senior management, and a decision will be communicated within 10 business days.

3.4 Technical Issues (Online Services) If you experience technical issues during an online assessment or consultation that prevent the completion of the service, you may be eligible for a partial or full refund depending on the extent of the disruption. A full refund will be issued if the service cannot be rescheduled or completed due to technical issues caused by Brightpath Neuro.

No refund will be issued if the technical issue is due to the client’s equipment or internet connection.

4. Non-Refundable Circumstances Refunds will not be granted in the following cases: If you fail to attend an appointment without prior notice. If you cancel less than 24 hours before the appointment (unless under exceptional circumstances). If the service was completed as described and in line with professional standards. If you disagree with the outcome of a professional assessment but the process and delivery were conducted in line with best practices. If you fail to provide necessary information or documentation required to complete the service.

5. How to Request a Refund To request a refund, you must contact us via: Email: [email protected] Phone: +44 20 3856 8602 Please include the following details in your refund request: Full name Date of service Reason for refund request Supporting documents (if applicable)

6. Processing Refunds Approved refunds will be processed within

7 business days of the decision. Refunds will be issued using the original payment method. If the original payment method is unavailable, an alternative refund method will be agreed upon with the client. 7. Disputed Refunds If you disagree with the outcome of a refund request, you may escalate the matter by contacting the Director of Clinical Services at Brightpath Neuro. A review will be conducted within 10 business days, and the outcome will be communicated in writing. If you remain dissatisfied, you may contact the relevant regulatory body (e.g., Care Quality Commission (CQC)) for further resolution.

8. Statutory Rights This Refund Policy does not affect your statutory rights under the Consumer Rights Act 2015 or other applicable laws.

9. Policy Review This policy will be reviewed annually to ensure compliance with UK consumer protection laws and healthcare regulations. Any updates or changes will be communicated to clients through our website and booking confirmation materials..

1. Introduction At Brightpath Neuro, we aim to provide accurate and evidence-based diagnostic services for neurodiversity and mental health conditions. We understand that clients may wish to seek clarification or challenge the outcome of a diagnosis if they feel it is inaccurate or incomplete. This policy outlines the process for appealing a diagnosis or assessment outcome, ensuring that all concerns are addressed fairly, professionally, and in line with clinical and professional standards.

👉 Submit an Appeal

2. Scope This policy applies to all diagnostic assessments provided by Brightpath Neuro, including but not limited to: ADHD Assessments Autism (ASC) Assessments Dyslexia Assessments Sleep Assessments Weight Management and Mood Assessments It applies to all clients who have undergone a formal assessment and received a written report or diagnosis.

3. Grounds for Appeal You may request a review or appeal of a diagnosis if you believe that: The assessment process was incomplete or not carried out according to professional guidelines. Relevant clinical information was not considered during the assessment. The diagnostic criteria were misapplied. There was a factual or clerical error in the report. You have obtained new evidence that was not available during the original assessment.

4. Appeal Process

Step 1 – Informal Resolution Before submitting a formal appeal, we encourage you to contact Brightpath Neuro to discuss your concerns with the clinician who conducted the assessment. You must raise your concerns within 14 calendar days of receiving the diagnosis or report. The clinician will review the assessment details and attempt to resolve any misunderstandings or provide further clarification. If you remain dissatisfied, you may proceed to a formal appeal.

Step 2 – Formal Appeal Submission To submit a formal appeal, you must send a written request to Brightpath Neuro within 28 calendar days of receiving the diagnosis or report. Your written request must include: Your full name and contact details. The date and type of assessment. A detailed explanation of why you believe the diagnosis is inaccurate or incomplete. Any supporting evidence (e.g., medical reports, third-party assessments). Submit your appeal to: Email: [email protected]

Step 3 – Appeal Review Upon receiving your appeal, the following process will apply: Initial Acknowledgement: We will acknowledge receipt of your appeal within 2 working days. Independent Review: An independent clinician (not involved in the original assessment) will be appointed to review the case. The review will assess: Whether the correct diagnostic procedures were followed. Whether all relevant information was considered. Whether the conclusions reached were reasonable based on the evidence provided. Decision and Outcome: The review will be completed within 14 calendar days of receiving the appeal. You will receive a written response detailing the outcome, which may include: Confirmation that the original diagnosis was accurate. A revised diagnosis based on additional evidence or clinical review. An offer to conduct a further assessment (at no additional cost).

Step 4 – Further Action If you remain dissatisfied with the outcome of the appeal, you may: Request a second independent opinion from a different clinician (subject to availability). Refer the matter to the Director of Clinical Services for a final review. Seek external resolution through the relevant regulatory bodies, including: Care Quality Commission (CQC): Website: www.cqc.org.uk Phone: 03000 616161 Professional Body for Registered Clinicians: British Psychological Society (BPS) Nursing and Midwifery Council (NMC)

5. Outcomes and Resolutions Following the outcome of the appeal, Brightpath Neuro may: Amend the diagnosis and update the report (if the appeal is upheld). Offer a follow-up assessment at no additional cost (if new evidence is presented). Provide further support or recommendations based on the review outcome. Maintain the original diagnosis if the appeal is not supported by clinical evidence.

6. Confidentiality and Data Protection All appeal information will be treated as confidential and handled in accordance with the UK General Data Protection Regulation (UK GDPR) and the Data Protection Act 2018. Only staff directly involved in the review process will have access to appeal information.

7. Time Limits Appeals must be submitted within 28 calendar days of receiving the diagnosis or report. Appeals submitted after this period will only be considered under exceptional circumstances (e.g., medical emergencies).

8. Limitations This policy does not cover: Disagreements with professional opinions if the correct process was followed and the diagnosis was clinically justified. Situations where the client has failed to provide full or accurate information during the assessment process. Requests to alter a diagnosis solely for the purpose of accessing benefits or accommodations.

9. Complaints If you wish to make a complaint about the appeals process or the handling of your case, you may follow our Complaints Policy (available on our website or upon request).

10. Monitoring and Review All appeals will be logged and monitored to identify trends and improve the quality of our services. This policy will be reviewed annually or in response to regulatory changes.

Your Rights at Brightpath Neuro At Brightpath Neuro, we are committed to protecting your rights and ensuring that you receive the highest standard of care. We recognise and respect your legal rights as a client, and we aim to provide a safe, supportive, and professional environment at all times. This document outlines your rights when using our services and how we protect and uphold those rights.

1. Your Right to Be Treated with Dignity and Respect You have the right to: Be treated with dignity, respect, and professionalism at all times. Be listened to without judgment or discrimination. Receive services in a safe, inclusive, and non-discriminatory environment. Be free from abuse, harassment, exploitation, and neglect.

2. Your Right to Confidentiality and Privacy You have the right to: Have your personal and medical information handled in accordance with the UK General Data Protection Regulation (UK GDPR) and the Data Protection Act 2018. Request that information about you is not shared without your consent, unless there is a legal obligation or safeguarding concern. Access information about how your data is used, stored, and protected (see our Privacy Policy).

3. Your Right to Access Your Records You have the right to: Request a copy of your personal records or assessment reports. Have factual inaccuracies in your records corrected promptly. Request that non-essential information is removed from your records (subject to legal requirements). Receive a response to your request within 30 days (in line with UK GDPR).

4. Your Right to Make Decisions About Your Care You have the right to: Be involved in all decisions regarding your care and treatment. Give or withhold consent for treatment or services. Change your mind and withdraw consent at any time without consequence. Refuse any assessment, treatment, or recommendation (unless legally required). Appoint an advocate or representative to support you in making decisions.

5. Your Right to Be Informed You have the right to: Be informed about the nature, purpose, risks, and benefits of any service offered. Be provided with clear and accurate information about your diagnosis, treatment options, and next steps. Receive communication in a format that is accessible and understandable to you (e.g., large print, easy read). Ask questions and receive honest and timely answers.

6. Your Right to Complain or Appeal You have the right to: Make a complaint if you are dissatisfied with any aspect of your care or service. Appeal a diagnosis or clinical decision if you disagree with the outcome (see our Diagnosis Appeal Policy). Have your complaint or appeal handled fairly, confidentially, and without fear of retaliation. Escalate your complaint to an independent authority if you remain dissatisfied (e.g., Care Quality Commission (CQC)).

7. Your Right to Access and Equality You have the right to: Access Brightpath Neuro’s services regardless of age, gender, race, ethnicity, disability, sexual orientation, or religious belief. Request reasonable adjustments to accommodate any disability or specific need. Have your cultural and religious values respected in your care. Be supported in your preferred language or communication style, where possible.

8. Your Right to Be Safe and Protected You have the right to: Receive services in a safe and supportive environment. Be protected from harm, abuse, neglect, or exploitation. Report any concerns about your safety to Brightpath Neuro without fear of reprisal. Have your safeguarding concerns investigated and acted upon promptly.

9. Your Right to Withdraw from Services You have the right to: Withdraw from any service at any time without consequence (unless legally required). Request a transfer of your care to another provider if you wish to change service providers. Refuse any involvement in research, training, or observation without affecting your care.

10. Your Right to Support and Advocacy You have the right to: Appoint an advocate, family member, or legal representative to support you in making decisions. Request an independent advocate if you feel unable to express your views effectively. Be supported by someone you trust during assessments, meetings, and consultations. Be informed of local advocacy and support services available to you.

11. Your Right to Non-Discrimination You have the right to receive services without discrimination on the grounds of: Age Disability Gender identity Sexual orientation Race or ethnicity Religion or belief Marital or civil partnership status Pregnancy or maternity Socioeconomic background

12. Your Right to Continuity of Care You have the right to: Receive consistent and continuous care from Brightpath Neuro. Be informed of any changes to your care plan or diagnosis. Request a second opinion if you are unsure about a diagnosis or treatment recommendation. Have access to follow-up care or reviews if needed.

13. Your Right to Feedback and Improvement You have the right to: Provide feedback on your experience with Brightpath Neuro. Suggest improvements to services without fear of retaliation. Have your feedback acknowledged and acted upon where possible. Receive a response to any formal feedback within 10 business days.

14. How We Protect Your Rights Brightpath Neuro is committed to upholding your rights by: Providing all staff with training on client rights, equality, and diversity. Monitoring service delivery to ensure compliance with client rights and legal standards. Investigating any reports of rights violations and taking corrective action where necessary. Seeking feedback from clients to improve the quality and accessibility of our services.

15. How to Exercise Your Rights If you wish to exercise any of your rights or need further information, you can contact us directly: Email: [email protected]

Bright Path Neuro is NOT a crisis service. If you are in crisis or need urgent support, please reach out to the appropriate services listed below:

🚨 Emergency Services (Immediate Danger)

Call 999 – If you are in immediate danger or need urgent medical attention. Go to your nearest A&E (Accident and Emergency) – If you require urgent medical care or are at risk of harming yourself or others.

📞 24/7 Crisis Support Helplines

Samaritans – Call 116 123 (free, open 24/7) For emotional support and someone to listen without judgment.

Shout – Text 85258 (free, open 24/7) For immediate support via text message.

Childline – Call 0800 1111 (free, open 24/7) For support if you are under 19.

National Suicide Prevention Helpline – Call 0800 689 5652 (open 24/7) For free and confidential support with thoughts of suicide.

🏥 Mental Health Crisis Teams

Contact your local NHS Mental Health Crisis Team – Find your local team by calling NHS 111 (open 24/7). If you are already under the care of a mental health team, contact them directly for advice and support.

💬 Non-Emergency Mental Health Support

Mind – Call 0300 123 3393 or text 86463

For mental health information and support (available 9 am – 6 pm, Monday to Friday).

CALM (Campaign Against Living Miserably) – Call 0800 58 58 58 (open 5 pm – midnight)

For support with mental health and suicidal thoughts.

If you need support but are not in immediate danger, please reach out to your GP or local mental health services.

Yes, our team consists of highly experienced and qualified healthcare professionals. Our Clinical Lead has over 30 years of experience in health and social care. He is an Advanced Mental Health Nurse Practitioner, a Fellow of the Society of Education and Training, and a Non-Medical Prescriber. All our staff are fully trained in: QB Test (for ADHD assessments) ADOS-2 and ADI-R (for autism assessments) Sleep and Weight Management We provide a holistic care package tailored to each individual's needs, combining expert knowledge with compassionate care.

Each service follows its own pathway, but we aim to provide you with an outcome within 24 hours after receiving the final piece of evidence. Our streamlined process ensures a quick turnaround without compromising the quality and depth of the assessment.

If medication is recommended as part of your treatment, a Signature RX prescription will be issued by our prescribing team. The prescription can be sent directly to your preferred pharmacy for collection or delivery. You'll receive clear instructions on how to take your medication, and our team will be available to support you with any questions or adjustments needed.